Document:

Exhibit 10.3

 

[Series D Preferred Stock]

 

SECURITIES PURCHASE AGREEMENT

 

This Securities Purchase Agreement (this
“Agreement”) is dated as of September 15, 2016 by and between Grandparents.com, Inc., a Delaware corporation
(the “Company”), and VB Funding, LLC, a Delaware limited liability company, or its assigns (the “Purchaser”).

 

WHEREAS, subject to the terms and
conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, the Company desires
to issue and sell to the Purchaser, and the Purchaser desires to purchase from the Company, certain securities of the Company as
more fully described in this Agreement.

 

NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of
which are hereby acknowledged, the Company and the Purchaser agree as follows:

 

ARTICLE I

 

DEFINITIONS

 

1.1         Definitions.
In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings indicated:

 

“Action” means any
claim, action, cause of action, demand, lawsuit, arbitration, inquiry, audit, notice of violation, proceeding, litigation, citation,
summons, subpoena or investigation of any nature, civil, criminal, administrative, regulatory or otherwise, whether at law or in
equity.

 

“Affiliate” means any Person
that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a
Person, as such terms are used in and construed under Rule 144 under the Securities Act.

 

“Business Day” means any
day other than Saturday, Sunday or other day on which banking institutions in New York, New York are authorized or required by
law or other government action to remain closed.

 

“Certificate
of Designation” means the certificate of designation for the Series D Preferred Stock in the in the form of Exhibit
A attached hereto.

 

“Charter Amendment” has
the meaning given to it in Section 5.3.

 

“Closing” means the closing
of the purchase and sale of the Shares pursuant to Section 2.2 hereof.

 

“Closing Date” means the
date of the Closing.

 

“Commission”
means the Securities and Exchange Commission.

 

“Common Stock”
means the common stock of the Company, par value $0.01 per share.

 

     

     

    

 

“Common Stock Purchase Agreement”
means that certain Securities Purchase Agreement, dated as of the date hereof, between the Company and the Purchaser, as the same
may be amended, restated, modified or supplemented from time to time, pursuant to which the Company shall issue to the Purchaser,
and the Purchaser shall acquire (subject to the terms and conditions set forth therein), an aggregate of 70,000,000 shares of Common
Stock of the Company. 

 

“Code” means the Internal
Revenue Code of 1986, as amended, including the regulations and published interpretations thereunder.

 

“Credit Agreement”
means that certain Amended and Restated Credit Agreement, dated as of the date hereof, between the Company, as borrower, and
the Purchaser, as lender, as the same may be amended, restated, modified or supplemented from time to time.

 

“D&O
Indemnification Agreement” has the meaning given to it in Section 4.1(m)(iii).

 

“Environmental
Laws” has the meaning given to it in Section 3.1(y).

 

“ERISA”
means the Employee Retirement Income Security Act of 1974, as amended, including the regulations and published interpretations
thereunder.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

“GAAP”
has the meaning given to it in Section 3.1(i).

 

“Governmental Authority” means
any federal, state, local or foreign government or political subdivision thereof, or any agency or instrumentality of such government
or political subdivision, or any self-regulated organization or other non-governmental regulatory authority or quasi-governmental
authority (to the extent that the rules, regulations or orders of such organization or authority have the force of Law), or any
arbitrator, court or tribunal of competent jurisdiction.

 

“Insolvent” means, with
respect to any Person, (a) the present fair saleable value of such Person’s assets is less than the amount required to pay
such Person’s debts as they become due, (b) such Person is unable to pay its debts and liabilities, subordinated, contingent
or otherwise, as such debts and liabilities become absolute and matured or (c) such Person has unreasonably small capital with
which to conduct the business in which it is engaged as such business is now conducted and is currently proposed to be conducted.

 

“Law” means any statute,
law, ordinance, regulation, rule, code, order, constitution, treaty, common law, judgment, decree, other requirement or rule of
law of any Governmental Authority.

 

    	 	2	 

     

    

 

“Lien” means any lien (statutory
or other), charge, claim, security interest, encumbrance, pledge, condition, equitable interest, option, mortgage, right of first
refusal or other restriction of any kind, including any restriction on use, voting, transfer, receipt of income or exercise of
any other attribute of ownership; other than liens securing the Obligations (as defined in the Credit Agreement) and any other
Permitted Liens (as defined in the Credit Agreement).

 

“Losses”
has the meaning given to it in Section 6.1.

 

“Material Adverse Effect” has
the meaning given to it in Section 3.1(a).

 

“Material Contracts” has
the meaning given to it in Section 3.1(o).

 

“Person” means any individual
or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint
stock company, government (or an agency or subdivision thereof) or any court or other federal, state, local or other Governmental
Authority or other entity of any kind.

 

“Registration Rights Agreement”
means that certain Amended and Restated Registration Rights Agreement, dated as of the date hereof, between the Company and
the Purchaser, as the same may be amended, restated, modified or supplemented from time to time.

 

“Rule 144” means
Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar
rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“SEC Reports”
has the meaning given to it in Section 3.1(h).

 

“Securities”
means the Shares.

 

“Securities
Act” means the Securities Act of 1933, as amended.

 

“Series C Preferred
Stock” has the meaning given to it in Section 3.1(e)(i).

 

“Series D Preferred
Stock” means the Series D Convertible 12% Preferred Stock of the Company, par value $0.01 per share, having the rights,
preferences, powers and privileges set forth in the Certificate of Designation.

 

“Shares”
means an aggregate of 1,500,000 shares of Series D Preferred Stock, which are being issued and sold to the Purchaser at the Closing.

 

“Short Sale”
has the meaning given to it in Section 3.2 (f).

 

“Tax” or “Taxes”
means any foreign, federal, state or local income, gross receipts, license, payroll, employment, excise, severance, stamp,
occupation, premium, property, windfall, profits, environmental, customs, capital stock, franchise, employees' income withholding,
foreign or domestic withholding, social security, unemployment, disability, real property, personal property, sales, use, transfer,
value added, alternative or add-on minimum or other similar tax, governmental fee, governmental assessment or governmental charge,
including any interest, penalties or additions to Taxes or additional amounts with respect to the foregoing. 

 

    	 	3	 

     

    

 

“Tax Returns” means all
returns, reports, or statements required to be filed with respect to any Tax (including any elections, notifications, declarations,
schedules or attachments thereto, and any amendment thereof) including any information return, claim for refund, amended return
or declaration of estimated Tax.

 

“Trading Market” means
whichever of the New York Stock Exchange, the American Stock Exchange, the NASDAQ Global Select Market, the NASDAQ Global Market,
the NASDAQ Capital Market, OTCQX or OTCQB on which the Common Stock is listed or quoted for trading on the date in question.

 

“Transaction Documents”
means (a) this Agreement, the schedules and exhibits attached hereto, and any other documents or agreements executed in connection
with the transactions contemplated hereunder; (b) the Certificate of Designation; (c) the Charter Amendment; (d) the Common Stock
Purchase Agreement, the schedules and exhibits thereto, and any other documents or agreements executed in connection with the transactions
contemplated thereunder; (e) the Registration Rights Agreement; and (f) the Credit Agreement, the schedules and exhibits thereto,
and any other documents or agreements executed in connection with the transactions contemplated thereunder.

 

ARTICLE II

 

PURCHASE AND SALE

 

2.1         Purchase
and Sale. Subject to the terms and conditions set forth in this Agreement, at the Closing the Company shall issue and sell
to the Purchaser, and the Purchaser shall purchase from the Company, the Shares, for an aggregate purchase price equal to $1,000,000.

 

2.2         Closing.
Subject to the terms and conditions of this Agreement, the closing of the purchase and sale of the Shares contemplated hereby (the
“Closing”) shall occur on the earliest practicable business day after all of the conditions set forth in Article
IV are either satisfied or waived (other than conditions which, by their nature, are to be satisfied on the Closing Date),
or at such other time and dates as the parties may mutually agree upon in writing. The Closing shall take place by delivery of
documents required to be delivered hereby by e-mail, facsimile or other electronic transmission.

 

2.3         Deliveries.

 

(a)          At
the Closing, the Purchaser shall deliver or cause to be delivered to the Company: (i) the purchase price set forth in Section
2.1 above, in United States dollars and in immediately available funds, by wire transfer to an account designated in writing
by the Company for such purpose; and (ii) the Transaction Documents and all other agreements, documents, instruments or certificates
required to be delivered by the Purchaser at or prior to the Closing pursuant to this Agreement.

 

    	 	4	 

     

    

 

(b)          At
the Closing, the Company shall deliver or cause to be delivered to the Purchaser the following: (i) one or more stock certificates,
free and clear of all restrictive and other legends (except as expressly provided in Section 5.1 hereof), evidencing the
number of Shares in Section 2.1 above, registered in the name of the Purchaser or such Affiliate thereof as the Purchaser
may designate in writing; (ii) the Transaction Documents and all other agreements, documents, instruments or certificates required
to be delivered by the Company at or prior to the Closing pursuant to this Agreement; and (iii) the documents, agreements and instruments
required under Section 4.1 below.

 

2.4         Use
of Proceeds. The proceeds from the issuance of the Shares shall be used by the Company to fund its operations and for the
payment of fees and expenses associated with the transactions contemplated hereby and shall not be used for any other purpose including,
without limitation, the payment of existing indebtedness of the Company.

 

ARTICLE III

 

REPRESENTATIONS AND WARRANTIES

 

3.1         Representations
and Warranties of the Company. The Company hereby represents and warrants to the Purchaser as follows:

 

(a)          Organization
and Qualification. The Company is a corporation duly incorporated, validly existing and in good standing under the laws of
the State of Delaware, with the requisite power and authority to own and use its properties and assets and to carry on its business
as currently conducted. The Company is duly qualified to do business and is in good standing as a foreign corporation in each jurisdiction
in which the operation of the business as currently conducted or property owned by it makes such qualification necessary, except
where the failure to be so qualified or in good standing, as the case may be, would not, (i) adversely affect the legality, validity
or enforceability of any Transaction Document, (ii) have or result in a material adverse effect on the results of operations, assets,
prospects, business or condition (financial or otherwise) of the Company, taken as a whole, or (iii) adversely impair the Company’s
ability to perform fully on a timely basis its obligations under any of the Transaction Documents (any of (i), (ii) or (iii), a
“Material Adverse Effect”).

 

(b)          Authorization;
Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by each of the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery
of each of the Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby
have been duly authorized by all necessary corporate action on the part of the Company and no further consent or action is required
by the Company, its Board of Directors or its stockholders. Each of the Transaction Documents has been (or upon delivery will be)
duly executed by the Company and is, or when delivered in accordance with the terms hereof will constitute, the valid and binding
obligation of the Company enforceable against the Company in accordance with its terms, except as such enforceability may be limited
by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally and by general
principles of equity (regardless of whether enforcement is sought in an Action at law or in equity).

 

    	 	5	 

     

    

 

(c)          No
Conflicts. The execution, delivery and performance of this Agreement and the other Transaction Documents by the Company and
the consummation by the Company of the transactions contemplated hereby and thereby do not and will not (i) conflict with or result
in the violation or breach of any provision of the Company’s certificate or articles of incorporation, bylaws or other organizational
or charter documents, (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would
become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation (with or without
notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company debt or otherwise)
or other understanding to which the Company is a party or by which any property or asset of the Company is bound or affected, except
to the extent that such conflict, default or, termination right could not reasonably be expected to have a Material Adverse Effect,
or (iii) result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other requirement or rule of
any court or Governmental Authority applicable to the Company (including federal and state securities laws and regulations and
the rules and regulations of any self-regulatory organization to which the Company or its securities are subject), except to the
extent that such violation would not have a Material Adverse Effect.

 

(d)          Consents
and Approvals. Except for any Current Report on Form 8-K to be filed by the Company in connection with the transactions contemplated
hereby or any required federal and/or state securities filings applicable to the offering of the Shares, (i) the Company is not
required to give any notice to, make any filing with, or obtain any authorization, consent, or approval of any Governmental Authority
in order to consummate the transactions contemplated hereby and by the other Transaction Documents and (ii) no consent, approval,
authorization or other order of, or registration, qualification or filing with, any court, regulatory body, administrative agency,
self-regulatory organization, stock exchange or market (including any Trading Market), or other Governmental Authority is required
for the execution and delivery of this Agreement and other Transaction Documents, or the valid issuance, sale and delivery of the
Shares to be sold pursuant to this Agreement other than such as have been made or obtained.

 

(e)          Capitalization.

 

(i)          The
authorized capital stock of the Company as of the date hereof consists of: (A) 5,000,000 shares of preferred stock, of which 875,000
shares are designated as Series C Redeemable Convertible 7.5% Preferred Stock, par value $0.01 per share (the “Series
C Preferred Stock”), of which 875,000 shares are issued and outstanding, and (B) 350,000,000 shares of Common Stock,
of which (1) 202,268,582 are issued and outstanding, (2) 323,433,168 shares are issued and outstanding on a fully-diluted, as converted
and as exercised basis, and (3) 18,522,500 shares are reserved for issuance upon exercise of outstanding stock options issued pursuant
to the Company’s Amended and Restated 2012 Stock Incentive Plan. There are no other classes of capital stock of the Company
authorized, issued or outstanding.

 

    	 	6	 

     

    

 

(ii)         Schedule
3.1(e) attached hereto sets forth sets forth, as of immediately following the Closing after giving effect to the transactions
contemplated by this Agreement (including the Charter Amendment), all outstanding or authorized (A) stock options under the Company’s
Amended and Restated 2012 Stock Incentive Plan and (B) any warrants, convertible securities or other rights, agreements, arrangements
or commitments of any character relating to the capital stock of the Company or obligating the Company to issue or sell any shares
of capital stock of, or any other interest in, the Company, in each case, including the number and kind of securities reserved
for issuance on exercise or conversion of any such securities or other rights, the exercise or conversion price of any such securities
or other rights and any applicable vesting schedule for any such securities or other rights. The Company does not have outstanding,
authorized, or in effect any stock appreciation, phantom stock, profit participation or similar rights. Except as set forth in
Schedule 3.1(e), there are no voting trusts, stockholder agreements, proxies or other agreements, understandings or obligations
in effect with respect to the voting, transfer or sale (including any rights of first refusal, rights of first offer or drag-along
rights), issuance (including any pre-emptive or anti-dilution rights), redemption or repurchase (including any put or call or buy-sell
rights), or registration (including any related lock-up or market standoff agreements) of any shares of capital stock or other
securities of the Company.

 

(f)          Issuance
of the Securities. As of immediately following the Closing after giving effect to the transactions contemplated by this Agreement
(including the Charter Amendment), (i) all of the issued and outstanding shares of capital stock of the Company, including the
Securities, when issued and paid for in accordance with the Transaction Documents, will have been duly authorized, validly issued,
fully paid and non-assessable, free and clear of all Liens and shall not be subject to preemptive rights or similar rights of stockholders,
(ii) all of the issued and outstanding shares of capital stock of the Company will have been issued in compliance with all applicable
federal and state securities Laws, (iii) none of the issued and outstanding shares of capital stock of the Company will have been
issued in violation of any agreement, arrangement or commitment to which the Company or any of its Affiliates is a party or is
subject to or in violation of any preemptive or similar rights of any Person, and (iv) all of the Shares will have the rights,
preferences, powers and privileges set forth in the Certificate of Designation and under the Delaware General Corporation Law.
The shares of Common Stock issuable upon conversion of the Shares in accordance with the Certificate of Designation have been duly
reserved for issuance and, upon such issuance, such shares of Common Stock will be (x) duly authorized, validly issued, fully paid
and non-assessable and (y) issued in compliance with applicable all federal and state securities Laws.

 

(g)          Subsidiaries.
Schedule 3.1(g) sets forth a list of the Company’s subsidiaries. All the issued and outstanding shares of each subsidiary’s
capital stock have been duly authorized and validly issued, are fully paid and nonassessable, have been issued in compliance with
all federal and state securities Laws, were not issued in violation of or subject to any preemptive rights or other rights to subscribe
for or purchase securities, and are owned by the Company or a Company subsidiary free and clear of all Liens.

 

    	 	7	 

     

    

 

(h)          SEC
Reports. The Company has filed all material reports required to be filed by it under the Securities Act and the Exchange Act,
including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the
Company was required by Law to file such material) (the foregoing materials, along with any materials incorporated by reference
therein, being collectively referred to herein as the “SEC Reports”) on a timely basis or has received a valid
extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their
respective dates (or, if amended or superseded by a filing prior to the Closing Date, then on the date of such filing), the SEC
Reports filed by the Company complied in all material respects with the requirements of the Securities Act and the Exchange Act
and the rules and regulations of the Commission promulgated thereunder, and none of the SEC Reports, when filed (or, if amended
or superseded by a filing prior to the Closing Date, then on the date of such filing) by the Company, contained any untrue statement
of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading.

 

(i)          Financial
Statements. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable
accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing
(or, if amended or superseded by a filing prior to the Closing Date, then on the date of such filing. Such financial statements
have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during
the periods involved (“GAAP”), except as may be otherwise specified in such financial statements or the notes
thereto, and fairly present in all material respects the financial condition of the Company and its consolidated subsidiaries as
of the respective dates they were prepared and the results of operations and cash flows for the periods then ended, subject, in
the case of interim financial statements, to normal, and recurring year-end audit adjustments and the absence of notes.

 

(j)          Internal
Accounting Controls. Except as set forth in the SEC Reports, the Company maintains a system of internal accounting controls
sufficient to provide reasonable assurances that (i) transactions are executed in accordance with management’s general or
specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity
with GAAP and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management’s
general or specific authorization; and (iv) the recorded accountability for assets is compared with existing assets at reasonable
intervals and appropriate action is taken with respect to any differences. Except as set forth in the SEC Reports, the Company
has disclosure controls and procedures (as defined in Rules 13a-14 and 15d-14 under the Exchange Act) that are effective and designed
to ensure that (1) information required to be disclosed in the SEC Reports that it files or submits under the Exchange Act is recorded,
processed, summarized and reported, within the time periods specified by the Commission’s rules and regulations, and (2)
such information is accumulated and communicated to the Company’s management, including its principal executive officer and
principal financial officer, to allow timely decisions regarding required disclosure. The Company is otherwise in compliance in
all material respects with all applicable provisions of the Sarbanes-Oxley Act of 2002, as amended and the rules and regulations
promulgated thereunder.

 

    	 	8	 

     

    

 

(k)          Off-Balance
Sheet Arrangements. There is no transaction, arrangement or other relationship between the Company or its subsidiaries and
an unconsolidated or other off-balance sheet entity that is required to be disclosed by the Company in the SEC Reports and is not
so disclosed or that otherwise would be reasonably likely to have, individually or in the aggregate, a Material Adverse Effect.
There are no such transactions, arrangements or other relationships with the Company that may create contingencies or liabilities
that are not otherwise disclosed by the Company in the SEC Reports.

 

(l)          Insolvency.
The Company is not as of the date hereof, and after giving effect to the transactions contemplated hereby to occur at the Closing,
will not be Insolvent (as defined below).

 

(m)        Undisclosed
Liabilities. Except as set forth in the SEC Reports or as otherwise incurred in the ordinary course of business consistent
with past practice since the date of the most recent balance sheet included in the SEC Reports, the Company has no liabilities,
obligations or commitments of any nature whatsoever, asserted or unasserted, known or unknown, absolute or contingent, accrued
or unaccrued, matured or unmatured or otherwise.

 

(n)          Absence
of Certain Changes, Events and Conditions. Since the date of the most recent balance sheet included in the SEC Reports, and
other than in the ordinary course of business consistent with past practice or in connection with the transactions contemplated
hereby or by the other Transaction Documents, there has not been, with respect to the Company, any:

 

(i)          event,
occurrence or development that has had, or could reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect;

 

(ii)         amendment
of the charter, by-laws or other organizational documents of the Company;

 

(iii)        split,
combination or reclassification of any shares of its capital stock;

 

(iv)        issuance,
sale or other disposition of any of its capital stock, or grant of any options, warrants or other rights to purchase or obtain
(including upon conversion, exchange or exercise) any of its capital stock;

 

(v)         declaration
or payment of any dividends or distributions on or in respect of any of its capital stock or redemption, purchase or acquisition
of its capital stock;

 

(vi)        material
change in any method of accounting or accounting practice of the Company, except as required by GAAP or as disclosed in the notes
to the financial statements included in the SEC Reports;

 

(vii)       incurrence,
assumption or guarantee of any indebtedness for borrowed money except unsecured current obligations and liabilities incurred in
the ordinary course of business consistent with past practice;

 

    	 	9	 

     

    

 

(viii)      transfer,
assignment, sale or other disposition of any of the assets shown or reflected in the balance sheet of the Company or cancellation,
discharge or payment of any debts, liens or entitlements;

 

(ix)         any
capital investment in, or any loan to, any other Person;

 

(x)          acceleration,
termination, material modification or amendment to or cancellation of any material Contract (including, but not limited to, any
Material Contract) to which the Company is a party or by which it is bound;

 

(xi)         any
material capital expenditures;

 

(xii)        imposition
of any Lien upon any of the Company properties, capital stock or assets, tangible or intangible;

 

(xiii)       adoption,
modification or termination of any: (1) material employment, severance, retention or other agreement with any current or former
employee, officer, director, independent contractor or consultant, (2) employee benefit plan, or (3) collective bargaining or similar
agreement, in each case whether written or oral;

 

(xiv)      any
loan to (or forgiveness of any loan to), or entry into any other transaction with, any of its stockholders, directors, officers
and employees;

 

(xv)       entry
into a new line of business or abandonment or discontinuance of existing lines of business;

 

(xvi)      adoption
of any plan of merger, consolidation, reorganization, liquidation or dissolution or filing of a petition in bankruptcy under any
provisions of federal or state bankruptcy Law or consent to the filing of any bankruptcy petition against it under any similar
Law;

 

(xvii)     acquisition
by merger or consolidation with, or by purchase of a substantial portion of the assets or stock of, or by any other manner, any
business or any Person or any division thereof; or

 

(xviii)    any contract
or other agreement to do any of the foregoing, or any action or omission that would result in any of the foregoing.

 

    	 	10	 

     

    

 

(o)          Contracts.
Each indenture, contract, lease, mortgage, deed of trust, note agreement, loan or other agreement or instrument of a character
that is required to be described or summarized in the SEC Reports or to be filed as an exhibit to the SEC Reports under the rules
and regulations of the Commission (collectively, the “Material Contracts”) is so described, summarized or filed.
The Material Contracts to which the Company or its subsidiaries are a party have been duly and validly authorized, executed and
delivered by the Company and constitute the legal, valid and binding agreements of the Company or its subsidiaries, as applicable,
enforceable by and against the Company or its subsidiaries, as applicable, in accordance with their respective terms, except as
such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’
rights generally and by general principles of equity (regardless of whether enforcement is sought in an Action at law or in equity).
Except as set forth in Schedule 3.1(o) or the SEC Reports, (i) none of the Company or any other party thereto is in breach
of or default under (or is alleged to be in breach of or default under), or has provided or received any notice of any intention
to terminate, any Material Contract and (ii) no event or circumstance has occurred that, with notice or lapse of time or both,
would constitute an event of default under any Material Contract or result in a termination thereof or would cause or permit the
acceleration or other changes of any right or obligation or the loss of any benefit thereunder. Complete and correct copies of
each Material Contract (including all modifications, amendments and supplements thereto and waivers thereunder) have been made
available to the Purchaser.

 

(p)          Absence
of Litigation. Except as set forth in Schedule 3.1(p), (i) there is no Action before or by any court, public board,
Governmental Authority, self-regulatory organization or body pending or, to the knowledge of the Company, threatened against or
affecting the Company or any of its subsidiaries that if determined adversely to the Company or any of its subsidiaries could,
individually or in the aggregate, have a Material Adverse Effect, (ii) to the knowledge of the Company, no event has occurred or
circumstances exist that may give rise to, or serve as a basis for, any such Action and (iii) neither the Company nor any of its
subsidiaries is a party or subject to the provisions of any injunction, judgment, decree or order of any Governmental Authority
that could have, individually or in the aggregate, a Material Adverse Effect.

 

(q)          Compliance
with Laws; Permits. The Company and each of its subsidiaries has complied, and is now complying, with all Laws applicable to
it or its business, properties or assets. All permits, licenses, franchises, approvals, authorizations, registrations, certificates,
variances and similar rights obtained, or required to be obtained, from Governmental Authorities required for the Company or any
of its subsidiaries to conduct its business have been obtained and are valid and in full force and effect.

 

(r)          No
Violations. Except as set forth in Schedule 3.1(r), neither the Company nor any of its subsidiaries is in violation
of its respective organizational documents or in violation of any Law or order of any court or Governmental Authority (including
any Trading Market), or authority applicable to the Company or any of its subsidiaries, which violation, individually or in the
aggregate, would be reasonably likely to have a Material Adverse Effect. Except as set forth in Schedule 3.1(r), neither
the Company nor any of its subsidiaries is in default (and there exists no condition which, with or without the passage of time
or giving of notice or both, would constitute a default) in the performance of any Material Contract to which the Company or any
of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or by which the properties of the Company
are bound, which would be reasonably likely to have a Material Adverse Effect. There has not been, there is not pending or, to
the knowledge of the Company, contemplated, any investigation by the Commission involving the Company or any current or former
director or officer of the Company. The Company has not received any comment letter from the Commission relating to any SEC Reports
which has not been finally resolved. The Commission has not issued any stop order or other order suspending the effectiveness of
any registration statement filed by the Company under the Exchange Act or the Securities Act.

 

    	 	11	 

     

    

 

(s)          Title
to Assets; Properties. Except as set forth in Schedule 3.1(s), (1) the Company and its subsidiaries have good and marketable
title to all the properties and assets (both tangible and intangible) described as owned by them in the consolidated financial
statements included in the SEC Reports, free and clear of all Liens of any kind except (i) those, if any, reflected in such
consolidated financial statements (including the notes thereto), or (ii) those that are not material in amount and do not
adversely affect the use made and proposed to be made of such property by the Company or its subsidiaries; (2) the Company and
each of its subsidiaries hold their leased properties under valid and binding leases; (3) the Company and each of its subsidiaries
own or lease all such properties as are necessary to its operations as now conducted; and (4) the use and operation of such properties
in the conduct of the Company’s business do not violate in any material respect any Law, covenant, condition, restriction,
easement, license, permit or agreement.

 

(t)          Intellectual
Property.

 

Except as set forth in Schedule 3.1(t);

 

(i)          The
Company (and/or its subsidiaries) owns or possesses, free and clear of all Liens, all legal rights to all intellectual property
(whether registered or unregistered) and rights in confidential information, including all (i) patents, patent applications, invention
disclosures, and all related continuations, continuations-in-part, divisional, reissues, re-examinations, substitutions and extensions
thereof, (ii) trademarks, trademark rights, service marks, service mark rights, corporate names, trade names, trade name rights,
domain names, logos, slogans, trade dress, design rights, and other similar designations of source or origin, together with the
goodwill symbolized by and of the foregoing, (iii) trade secrets and all other confidential information, ideas, know-how, inventions,
proprietary processes, formulae, models, and other methodologies, (iv) copyrights, (v) computer programs (whether in object code,
subject code or other form), algorithms, databases, compilations and data, technology supporting the foregoing, and all related
documentation, (vi) licenses to any of the foregoing, (vii) all applications and registrations of the foregoing, and (viii) all
other similar proprietary rights (collectively, “Intellectual Property”) used or held for use in, or necessary
for the conduct of their businesses as now conducted and as proposed to be conducted. Neither the Company nor any of its subsidiaries
(A) has received any communications alleging that either the Company or any of its subsidiaries has violated, infringed or misappropriated
or, by conducting their businesses as now conducted and as proposed to be conducted, would violate, infringe or misappropriate
any of the Intellectual Property of any other Person, (B) knows of any basis for any claim that the Company or any of its subsidiaries
has violated, infringed or misappropriated, or, by conducting their businesses as now conducted and as proposed to be conducted,
would violate, infringe or misappropriate any of the Intellectual Property of any other Person, and (C) knows of any third-party
infringement, misappropriation or violation of any Company or any Company subsidiary’s Intellectual Property.

 

    	 	12	 

     

    

 

(ii)         The
Company has taken and takes reasonable security measures to protect the secrecy, confidentiality and value of its Intellectual
Property, including requiring all Persons with access thereto to enter into appropriate non-disclosure agreements. There has not
been any disclosure of any material trade secret of the Company or a Company subsidiary (including any such information of any
other Person disclosed in confidence to the Company) to any other Person in a manner that has resulted or is likely to result in
the loss of trade secret in and to such information. Except as in the ordinary course of business or as would not reasonably be
expected to have, individually or in the aggregate, a Material Adverse Effect, there are no outstanding options, licenses or agreements,
claims, encumbrances or shared ownership interests of any kind relating to the Company’s or its subsidiaries’ Intellectual
Property, nor is the Company or any of its subsidiaries bound by or a party to any options, licenses or agreements of any kind
with respect to the Intellectual Property of any other Person.

 

(iii)        None
of the employees of the Company or its subsidiaries are obligated under any contract (including, without limitation, licenses,
covenants or commitments of any nature or contracts entered into with prior employers), or subject to any judgment, decree or order
of any Governmental Authority, that would interfere with the use of his or her best efforts to promote the interests of the Company
or its subsidiaries or would conflict with their businesses as now conducted and as proposed to be conducted. Neither the execution
nor delivery of this Agreement and the other Transaction Documents will conflict with or result in a breach of the terms, conditions
or provisions of, or constitute a default under any contract, covenant or instrument under which the Company or its subsidiaries
or any of the employees of the Company or its subsidiaries is now obligated, and neither the Company nor its subsidiaries will
need to use any inventions that any of its employees, or Persons it currently intends to employ, have made prior to their employment
with the Company or its subsidiaries, except for inventions that have been assigned or licensed to the Company or its subsidiaries
as of the date hereof.

 

(iv)        Each
current and former employee or contractor of the Company or its subsidiaries that has developed any Intellectual Property owned
or purported to be owned by the Company or its subsidiaries has executed and delivered to the Company a valid and enforceable invention
assignment and confidentiality agreement that (A) assigns to the Company or such subsidiaries all right, title and interest in
and to any Intellectual Property rights arising from or developed or delivered to the Company or such subsidiaries in connection
with such Person’s work for or on behalf of the Company or such subsidiaries, and (B) provides reasonable protection for
the trade secrets, know-how and other confidential information (1) of the Company or such subsidiaries and (2) of any third party
that has disclosed same to the Company or such subsidiaries. No current or former employee, officer, consultant or contractor is
in default or breach of any term of any employment, consulting or contractor agreement, non-disclosure agreement, assignment agreement,
or similar agreement. No present or former employee, officer, consultant or contractor of the Company has any ownership, license
or other right, title or interest, directly or indirectly, in whole or in part, in any Intellectual Property that is owned or purported
to be owned, in whole or part, by the Company or its subsidiaries.

 

(u)          Insurance.
The Company and its subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and
in such amounts as are prudent and customary in the businesses in which the Company and its subsidiaries are engaged. The Company
and its subsidiaries will continue to maintain such insurance or substantially similar insurance, which covers the same risks at
the same levels as the existing insurance with insurers which guarantee the same financial responsibility as the current insurers,
and neither the Company nor any subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage
as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business
without a significant increase in cost.

 

    	 	13	 

     

    

 

(v)         Tax
Matters. The Company and its subsidiaries have filed all Tax Returns, and these Tax Returns are true, correct, and complete
in all material respects. The Company and each subsidiary (i) have paid all Taxes that are due from the Company or such subsidiary
for the periods covered by the Tax Returns or (ii) have duly and fully provided reserves adequate to pay all Taxes in accordance
with GAAP. No agreement as to indemnification for, contribution to, or payment of Taxes exists between the Company or any subsidiary,
on the one hand, and any other Person, on the other, including pursuant to any Tax sharing agreement, lease agreement, purchase
or sale agreement, partnership agreement or any other agreement not entered into in the ordinary course of business. Neither the
Company nor any of its subsidiaries has any liability for Taxes of any Person (other than the Company or any of its subsidiaries)
under Treasury Regulation Section 1.1502-6 (or any similar provision of any state, local or foreign law), or as a transferee or
successor, by contract or otherwise. Since the date of the Company’s most recent financial statements included in the SEC
Reports, the Company has not incurred any liability for Taxes other than in the ordinary course of business consistent with past
practice. Neither the Company nor its subsidiaries has been advised (A) that any of its Tax Returns have been or are being audited
as of the date hereof, or (B) of any deficiency in assessment or proposed judgment to its Taxes. Neither the Company nor any of
its subsidiaries has knowledge of any Tax liability to be imposed upon its properties or assets as of the date of this Agreement
that is not adequately provided for. No extensions or waivers of statutes of limitations have been given or requested with respect
to any Taxes of the Company. The Company has withheld and paid each Tax required to have been withheld and paid in connection with
amounts paid or owing to any employee, independent contractor, creditor, customer, stockholder or other party, and complied with
all information reporting and backup withholding provisions of applicable Law.

 

(w)        Transactions
with Affiliates and Employees. Except as set forth in Schedule 3.1(w) or the SEC Reports, none of the officers or directors
of the Company or its subsidiaries and none of the employees of the Company or its subsidiaries is presently a party to any transaction
with the Company or any subsidiary or Affiliate thereof (other than for services as employees, officers and directors required
to be disclosed under Item 404 of Regulation S-K under the Exchange Act).

 

(x)          Foreign
Corrupt Practices. Neither the Company nor any other Person associated with or acting on behalf of the Company, including,
without limitation, any director, officer, agent, employee or Affiliate of the Company has (i) used any corporate funds for any
unlawful contribution, gift, entertainment or other unlawful expense relating to political activity or to influence official action;
(ii) made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds;
(iii) made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment; or (iv) violated or is in violation
of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder; and the
Company has instituted and maintains policies and procedures designed to ensure compliance therewith.

 

    	 	14	 

     

    

 

(y)          Environmental
Laws. The Company and its subsidiaries (i) are in compliance with any and all applicable foreign, federal, state and local
laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or
wastes, pollutants or contaminants (“Environmental Laws”), (ii) have received all permits, licenses or other
approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii) are in compliance
with all terms and conditions of any such permit, license or approval, except where such noncompliance with Environmental Laws,
failure to receive required permits, licenses or other approvals or failure to comply with the terms and conditions of such permits,
licenses or approvals would not, individually or in the aggregate, have a Material Adverse Effect. There are no costs or liabilities
associated with Environmental Laws (including, without limitation, any capital or operating expenditures required for clean-up,
closure of properties or compliance with Environmental Laws or any permit, license or approval, any related constraints on operating
activities and any potential liabilities to third parties) which would, individually or in the aggregate, have a Material Adverse
Effect.

 

(z)          Employee
Relations.

 

(i)          Except
as set forth in Schedule 3.1(z)(i), as of the date hereof, all compensation, including wages, commissions and bonuses, payable
to employees, independent contractors or consultants of the Company or any of its subsidiaries for services performed on or prior
to the date hereof have been paid in full and there are no outstanding agreements, understandings or commitments of the Company
or any of its subsidiaries with respect to any employment, compensation, commissions or bonuses.

 

(ii)         Neither
the Company nor any of its subsidiaries is a party to any collective bargaining agreement or employs any member of a union. No
union organizing activities are currently taking place concerning the employees of the Company or any of its subsidiaries. There
is (A) no grievance or arbitration proceeding arising out of or under collective bargaining agreements is pending or threatened,
(B) no strike, labor dispute, slowdown or stoppage pending or, to the Company’s knowledge, threatened against the Company
or any of its subsidiaries and (C) no union representation dispute currently existing concerning the employees of the Company or
any of its subsidiaries.

 

(iii)        Except
as set forth in Schedule 3.1(z)(iii), (i) the Company is and has been in compliance with all applicable Laws pertaining
to employment and employment practices, including all Laws relating to labor relations, equal employment opportunities, fair employment
practices, employment discrimination, harassment, retaliation, reasonable accommodation, disability rights or benefits, immigration,
wages, hours, overtime compensation, child labor, hiring, promotion and termination of employees, working conditions, meal and
break periods, privacy, health and safety, workers’ compensation, leaves of absence and unemployment insurance, (ii) all
individuals characterized and treated by the Company as independent contractors or consultants are properly treated as independent
contractors under all applicable Laws, (iii) all employees classified as exempt under the Fair Labor Standards Act and state and
local wage and hour laws are properly classified and (iv) there are no Actions against the Company pending, or to the Company’s
knowledge, threatened to be brought or filed, by or with any Governmental Authority or arbitrator in connection with the employment
of any current or former applicant, employee, consultant or independent contractor of the Company, including, without limitation,
any claim relating to unfair labor practices, employment discrimination, harassment, retaliation, equal pay, wage and hours or
any other employment related matter arising under applicable Laws.

 

    	 	15	 

     

    

 

(iv)        No
executive officer of the Company (as defined in Rule 501(f) promulgated under the Securities Act) has notified the Company that
such officer intends to leave the Company or otherwise terminate such officer’s employment with the Company. No executive
officer of the Company is, or is expected to be, in violation of any material term of any employment contract, confidentiality,
disclosure or proprietary information agreement, non-competition agreement, or any other agreement or any restrictive covenant,
and the continued employment of each such executive officer does not subject the Company or any of its subsidiaries to any liability
with respect to any of the foregoing matters.

 

(aa)         ERISA.
The Company and its subsidiaries are in compliance in all material respects with all presently applicable provisions of ERISA.
No “reportable event” (as defined in ERISA) has occurred with respect to any “pension plan” (as defined
in ERISA) for which the Company or any of its subsidiaries would have any liability. The Company has not incurred and does not
expect to incur liability under (i) Title I or Title IV of ERISA (or related provisions of the Code or other Laws relating to employee
benefit plans) with respect to termination of, or withdrawal from, any “pension plan”; or (ii) Sections 412 or 4971
of the Code. Each pension plan for which the Company would have liability that is intended to be qualified under Section 401(a)
of the Code is so qualified in all material respects and nothing has occurred, whether by action or by failure to act, which would
cause the loss of such qualification. All benefits, contributions and premiums relating to each pension plan have been timely paid
in accordance with the terms of such pension plan and all applicable Laws and accounting principles, and all benefits accrued under
any unfunded pension plan have been paid, accrued or otherwise reserved to the extent required by, and in accordance with, GAAP.

 

(bb)         No
General Solicitation. Neither the Company nor its subsidiaries or any Affiliates, nor any Person acting on its or their behalf,
has offered or sold any of the Shares by any form of general solicitation or general advertising.

 

(cc)         Registration
Rights. Except as set forth in Schedule 3.1(cc) or the Amended and Restated Registration Rights Agreement to be entered
into as of the Closing Date, between the Company and the Purchaser, the Company has not granted or agreed to grant to any Person
any rights (including “piggy-back” registration rights) to have any securities of the Company registered with the Commission
or any other Governmental Authority.

 

(dd)         Application
of Takeover Protections. There is no control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or other similar anti-takeover provision under the Company’s charter documents or the laws of its
state of incorporation that is or could become applicable to the Purchaser as a result of the Purchaser and the Company fulfilling
their obligations or exercising their rights hereunder or under any of the other Transaction Documents, including, without limitation,
as a result of the Company’s issuance of the Shares and the Purchaser’s ownership of the Shares.

 

    	 	16	 

     

    

 

(ee)         Certain
Fees. The Company has not taken any action that would cause the Purchaser to be liable for any brokerage or finder’s
fees or commissions payable to any broker, financial advisor, consultant, finder, placement agent, investment banker, bank or other
Person engaged by the Company, if any, with respect to the transactions contemplated by this Agreement.

 

(ff)         Books
and Records. The minute books and stock record books of the Company, all of which have been made available to the Purchaser,
are complete and correct and have been maintained in accordance with sound business practices. The minute books of the Company
contain accurate and complete records of all meetings, and actions taken by written consent of, the stockholders, the board of
directors and any committees of the board of directors of the Company, and no meeting, or action taken by written consent, of any
such stockholders, board of directors or committee has been held for which minutes have not been prepared and are not contained
in such minute books.

 

(gg)         Private
Placement. Neither the Company nor any Person acting on the Company’s behalf has sold or offered to sell or solicited
any offer to buy the Securities by means of any form of general solicitation or advertising. Neither the Company nor any
of its Affiliates or any Person acting on the Company’s behalf has, directly or indirectly, at any time within the past six
months, made any offer or sale of any security or solicitation of any offer to buy any security under circumstances that would
(i) eliminate the availability of the exemption from registration under Regulation D under the Securities Act in connection with
the offer and sale of the Securities as contemplated hereby or (ii) cause the offering of the Securities pursuant to the Transaction
Documents to be integrated with prior offerings by the Company for purposes of any applicable law, regulation or stockholder approval
provisions. The Company is not, and is not an Affiliate of, an “investment company” within the meaning of the Investment
Company Act of 1940, as amended. The Company is not a United States real property holding corporation within the meaning of the
Foreign Investment in Real Property Tax Act of 1980.

 

3.2         Representations
and Warranties of Purchaser. The Purchaser hereby represents and warrants to the Company as follows:

 

(a)          Authority.
(i) The Purchaser is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its
organization with the requisite corporate, partnership, limited liability company or other organization power and authority to
enter into and to consummate the transactions contemplated by this Agreement and the other Transaction Documents to which it is
a party and otherwise to carry out its obligations hereunder and thereunder, (ii) the purchase by the Purchaser of the Securities
hereunder has been duly authorized by all necessary action on the part of the Purchaser, (iii) this Agreement and the other Transaction
Documents to which it is a party have been duly executed and delivered by the Purchaser and constitute valid and binding obligations
of the Purchaser enforceable against the Purchaser in accordance with the terms hereof and thereof, except as such enforceability
may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally
and by general principles of equity (regardless of whether enforcement is sought in an Action at law or in equity), and (iv) and
the Purchaser has its principal offices or principal place of business located at the address shown under Purchaser’s signature
at the end of this Agreement.

 

    	 	17	 

     

    

 

(b)          Investment
Intent. The Purchaser is acquiring the Securities as principal for its own account for investment purposes only and not with
a view to or for distributing or reselling such Securities or any part thereof, without prejudice, however, to the Purchaser’s
right, subject to the provisions of this Agreement, at all times to sell or otherwise dispose of all or any part of such Securities
pursuant to an effective registration statement under the Securities Act or under an exemption from such registration and in compliance
with applicable federal and state securities laws. Nothing contained herein shall be deemed a representation or warranty by the
Purchaser to hold Securities for any period of time. The Purchaser does not have any agreement or understanding, directly or indirectly,
with any Person to distribute any of the Securities.

 

(c)          Purchaser
Status. At the time the Purchaser was offered the Securities, it was, and at the date hereof, it is, an “accredited investor”
as defined in Rule 501(a) of Regulation D under the Securities Act. The Purchaser is not a registered broker-dealer under Section
15 of the Exchange Act.

 

(d)          Experience
of Purchaser. The Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. The Purchaser is able to bear the economic risk of an investment
in the Securities and, at the present time, is able to afford a complete loss of such investment.

 

(e)          Access
to Information. The Purchaser acknowledges that it has received and reviewed all information about the Company it considers
necessary or appropriate for deciding whether to acquire the Securities and has been afforded (i) the opportunity to ask such questions
as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions
of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the
Company and its subsidiaries and their respective financial condition, results of operations, business, properties, management
and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information
that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment
decision with respect to the investment. The Purchaser has sought such accounting, legal and tax advice as it has considered necessary
to make an informed decision with respect to its acquisition of the Securities.

 

(f)          Certain
Trading Limitations. The Purchaser agrees that beginning on the date hereof until ninety (90) days from the Closing Date, it
will not enter into any Short Sales. For purposes of this Section 3.2(f), a “Short Sale” means a sale
of Common Stock that is marked as a short sale and that is executed at a time when Purchaser has no equivalent offsetting long
position in the Common Stock. For purposes of determining whether the Purchaser has an equivalent offsetting long position in the
Common Stock, all Common Stock and all Common Stock that would be issuable upon conversion or exercise in full of all options then
held by Purchaser (assuming that such options were then fully convertible or exercisable, notwithstanding any provisions to the
contrary, and giving effect to any conversion or exercise price adjustments scheduled to take effect in the future) shall be deemed
to be held long by the Purchaser.

 

    	 	18	 

     

    

 

(g)          Certain
Fees. The Purchaser has not taken any action that would cause the Company to be liable for any brokerage or finder’s
fees or commissions payable to any broker, financial advisor, consultant, finder, placement agent, investment banker, bank or other
Person engaged by the Purchaser, if any, with respect to the transactions contemplated by this Agreement.

 

(h)          Restricted
Securities. The Purchaser understands that the Securities are characterized as “restricted securities” under the
U.S. federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering
and that under such laws and applicable regulations such securities may be resold without registration under the Securities Act
only in limited circumstances.

 

ARTICLE IV

 

CONDITIONS TO CLOSING

 

4.1         Conditions
to Obligations of the Purchaser. The obligations of the Purchaser to consummate the transactions contemplated by this Agreement
shall be subject to the fulfillment or the Purchaser’s waiver, at or prior to the Closing, of each of the following conditions:

 

(a)          The
Company shall have received all consents, authorizations, orders and approvals from the Commission and any other Governmental Authorities
necessary for the consummation of the transactions contemplated hereby, in each case, in form and substance reasonably satisfactory
to the Purchaser, and no such consent, authorization, order and approval shall have been revoked.

 

(b)          This
Agreement and each of the other Transaction Documents required to be delivered pursuant to Section 2.3(b) above shall have
been executed and delivered by the Company and the other parties thereto and true and complete copies thereof shall have been delivered
to the Purchaser.

 

(c)          The
Purchaser shall have completed its due diligence review, including a legal and financial review of the Company and its business,
which review shall be satisfactory to the Purchaser in its sole and absolute discretion.

 

(d)          The
Purchaser shall have received a certificate of the Secretary (or equivalent officer) of the Company certifying:

 

    	 	19	 

     

    

 

(i)          that
attached thereto are true and complete copies of all resolutions and other consents adopted by the board of directors of the Company
authorizing and approving the execution, delivery, filing and performance of this Agreement and the other Transaction Documents
and the consummation of the transactions contemplated hereby and thereby (including, without limitation, a resolution of the board
of directors to recommend to the stockholders of the Company that they approve the Charter Amendment, to call a special meeting
of the stockholders for purposes of approving the Charter Amendment and to approve all filings and notifications with the Commission,
any Trading Market or any other Governmental Authority necessary in connection with the approval of the Charter Amendment), and
that all such resolutions and consents are in full force and effect as of the Closing and are all the resolutions and consents
adopted in connection with the transactions contemplated hereby and thereby;

 

(ii)         that
attached thereto are true and complete copies of the certificate of incorporation and by-laws of the Company, each as amended and
in effect as of the date thereof, and that such organizational documents are in full force and effect as of the Closing; and

 

(iii)        the
names and signatures of the officers of the Company authorized to sign this Agreement, the other Transaction Documents and the
other documents to be delivered hereunder and thereunder.

 

(e)          The
Purchaser shall have executed a resolution, effective as of the Closing Date, appointing five (5) of the seven (7) members of the
board of directors of the Company.

 

(f)          The
Company shall have duly adopted the Certificate of Designation, which shall have been filed with the Secretary of State of Delaware
and become effective under the Delaware General Corporation Law on or prior to the Closing and which shall remain in full force
and effect as of the Closing, and the Purchaser shall have received a certificate of the Secretary of State of Delaware certifying
that the Certificate of Designation has been filed and is effective. The Certificate of Designation shall provide, among other
things, that each share of Series D Preferred Stock shall be convertible into 1,222 shares of Common Stock, as more particularly
set forth in the Certificate of Designation.

 

(g)          The
Company shall have duly adopted the Charter Amendment, which shall have been filed with the Secretary of State of Delaware and
become effective under the Delaware General Corporation Law on or prior to the Closing and which shall remain in full force and
effect as of the Closing, and the Purchaser shall have received a certificate of the Secretary of State of Delaware certifying
that the Charter Amendment has been filed and is effective.

 

(h)          Each
executive officer and director of the Company (and their respective family members and Affiliates to the extent they hold shares
of capital stock of the Company) shall have executed and delivered to the Purchaser a letter agreement pursuant to which such Person
agrees to vote all of his or her respective shares of Common Stock beneficially owned in favor of the Charter Amendment.

 

(i)          All
shares of Series C Preferred Stock held by any officer, director or executive of the Company (or their respective Affiliates and
family members) shall have been converted to shares of Common Stock at a conversion price of $0.05 per share and the Company shall
have delivered evidence (satisfactory to the Purchaser) of such conversion to the Purchaser.

 

    	 	20	 

     

    

 

(j)          Any
sales or consulting arrangements between the Company and any officer, director, executive or other insider (inclusive of Mel Harris)
or any Affiliate or family member thereof shall have been terminated, at no cost to the Company, by the mutual written agreement
of the Company and the party(ies) thereto and evidence of such terminations (satisfactory to the Purchaser) shall have been delivered
to the Purchaser.

 

(k)          Any
amendments or terminations of existing employment arrangements between the Company and any officer, director, executive, or other
insider or any Affiliate or family member required by the Purchaser shall have been completed upon terms and conditions acceptable
to the Purchaser and evidence of such amendments or terminations (satisfactory to the Purchaser) shall have been delivered to the
Purchaser.

 

(l)          The
Company shall have delivered to the Purchaser a good standing certificate (or its equivalent) for the Company from the Secretary
of State of Delaware.

 

(m)        The
Company shall have delivered, or caused to be delivered, to the Purchaser each of the following, each in form and substance satisfactory
to the Purchaser:

 

(i)          stock
certificates evidencing the Shares;

 

(ii)         an
opinion of legal counsel to the Company, dated as of the Closing Date;

 

(iii)        an
executed Indemnification Agreement, dated as of the Closing Date, substantially in the form Exhibit B attached hereto (“D&O
Indemnification Agreement”), for each of the Purchaser’s representatives designated to the board of directors of
the Company; and

 

(iv)        such
other documents or instruments as the Purchaser reasonably requests and are reasonably necessary to consummate the transactions
contemplated by this Agreement.

 

(n)          The
Company shall have fully complied with, or obtained appropriate consents or waivers with respect to, its obligations pursuant to
any outstanding rights of first refusal, rights of first offer, pre-emptive rights or anti-dilution rights or redemption or repurchase
rights.

 

(o)          The
Company shall have paid the fees and expenses of the Purchaser pursuant to the terms of Section 7.1 below.

 

4.2         Conditions
to Obligations of the Company. The obligations of the Company to consummate the transactions contemplated by this Agreement
shall be subject to the fulfillment or the Company’s waiver, at or prior to the Closing, of each of the following conditions:

 

(a)          This
Agreement and each of the other Transaction Documents required to be delivered pursuant to Section 2.3(a) above shall have
been executed and delivered by the Company and the other parties thereto and true and complete copies thereof shall have been delivered
to the Purchaser.

 

    	 	21	 

     

    

 

(b)          The
Purchaser shall have delivered to the Company cash in an amount equal to the purchase price for the Shares by wire transfer in
immediately available funds, to an account or accounts designated in writing by the Company to the Purchaser.

 

ARTICLE V

 

OTHER AGREEMENTS OF
THE PARTIES

 

5.1         Restricted
Securities; Transfers on Restrictions. The Purchaser understands that (i) the Securities are characterized as “restricted
securities” under the Securities Act; (ii) the Securities have not been and, except as otherwise provided herein, will not
be registered under the Securities Act or any state securities laws, and may not be offered for sale, sold, assigned or transferred
unless subsequently registered thereunder or the Purchaser shall have delivered to the Company an opinion of counsel, in a form
acceptable to the Company and from counsel reasonably acceptable to the Company, to the effect that such Securities to be sold,
assigned or transferred may be sold, assigned or transferred pursuant to an exemption from such registration, (iii) any sale of
the Securities made in reliance on Rule 144 may be made only in accordance with the terms of Rule 144, and further, if Rule 144
is not applicable, any resale of the Securities under circumstances in which the seller (or the Person through whom the sale is
made) may be deemed to be an underwriter (as that term is defined in the Securities Act) may require compliance with some other
exemption under the Securities Act or the rules and regulations of the Commission promulgated thereunder; and (iv) unless sold
pursuant to a registration statement that has been declared effective under the Securities Act or in compliance with Rule 144,
the Company requires that the Securities bear a legend referring to the foregoing restrictions (it being agreed that if the Securities
are not certificated, other appropriate restrictions shall be implemented to give effect to the foregoing) and shall place stop
order instructions with its transfer agent with respect to such Securities.

 

5.2         Integration.
The Company shall not, and shall use its commercially reasonable efforts to ensure that no Affiliate of the Company shall, sell,
offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities
Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the
Securities Act of the sale of the Securities to the Purchaser, or that would be integrated with the offer or sale of the Securities
for purposes of the rules and regulations of any Trading Market.

 

5.3         Approval
of Charter Amendment. As promptly as practicable after the execution of this Agreement, the Company shall take all actions
necessary under the Delaware General Corporation Law, the rules and regulations of the Commission and any applicable Trading Market
and otherwise under applicable Laws to call a special meeting of the stockholders of the Company, for the purpose of soliciting
stockholder approval of an amendment to the certificate of incorporation of the Company (the “Charter Amendment”)
providing for (i) a reverse stock split of the Company’s issued and outstanding shares of Common Stock at a ratio to be determined
and mutually agreed upon by the parties; and (ii) the increase in the authorized shares of Common Stock of the Company from 350,000,000
shares to 2,156,500,000 shares. In connection with such special meeting of the stockholders, the Company shall prepare and file
with the Commission such preliminary and definitive proxy statements (and any amendments thereto) and make any notifications or
filings required by any applicable Trading Market as may be necessary to properly call the special meeting of stockholders. All
such filings and notifications shall be in compliance with all applicable Commission and Trading Market rules and regulations.
The Company shall use its best efforts to solicit its stockholders approval of the Charter Amendment. The Company shall be obligated
to seek to obtain such approval within ninety (90) days from the date hereof. Upon obtaining stockholder approval, the Company
shall file the Charter Amendment with the Secretary of State of Delaware.

 

    	 	22	 

     

    

 

5.4         Covenants
of the Company. Unless the Company has received the prior written consent or waiver of the Purchaser, the Company shall
be subject to each of the following covenants:

 

(a)          The
Company shall, and shall cause its subsidiaries to, at all times maintain (i) under the Laws of the state of Delaware its valid
corporate existence and good standing, (ii) its due license and qualification to do business and good standing in each jurisdiction
in which the properties owned or leased by it or the operation of its business makes such licensing or qualification necessary
and (iii) all permits, licenses and authorizations necessary to the conduct of its businesses.

 

(b)          After
the Closing, the number of directors who shall constitute the entire board of directors of the Company shall be fixed at seven
(7) and five (5) persons serving as directors of the Company shall be appointed by the holder of a majority of the shares of Series
D Preferred Stock. The board of directors shall, at all times following the Closing, be responsible for the selection, hiring and
termination of the Chief Executive Officer of the Company.

 

(c)          Immediately
following the effective date of the Charter Amendment, the Company shall deliver a notice to all holders of the Series C Preferred
Stock (other than those holders identified in Section 4.1(i) above) offering such holders the option, exercisable for a
period of 30 days from such notice, to convert all shares of Series C Preferred Stock held by such holder into shares of Common
Stock at $0.05 per share; provided that, such holders must agree to such liability releases and covenants not to sue as may be
required by the Purchaser. The Company shall provide a copy of such notice to the Purchaser as well as any documents evidencing
the conversion of Series C Preferred Stock pursuant thereto.

 

(d)          The
Company shall, and shall cause its subsidiaries to, comply with all Laws applicable to it or its business, properties or assets,
the violation of which would reasonably be expected to have a Material Adverse Effect.

 

    	 	23	 

     

    

 

(e)          The
Company shall comply with the reporting requirements of the Exchange Act and each applicable Trading Market and timely file all
required SEC Reports (including a Current Report on Form 8-K upon the execution of this Agreement) and remain in compliance with
all applicable rules and regulations of the Commission and any applicable Trading Market. The Company shall promptly take any action
required to maintain the listing of all of the Shares, once they have been issued, upon each applicable Trading Market. The Company
shall make and keep public information available, as those terms are understood and defined in Rule 144, for so long as required
in order to permit the resale of the Shares pursuant to Rule 144 and to file periodic reports with the Commission whether or not
required to do so. The Company shall not take any action which would be reasonably expected to result in the delisting or
suspension of the Common Stock on any applicable Trading Market.

 

(f)          The
Company will draft and file with the Commission, at the Company’s expense, a Form 3 (or Form 4 if applicable) and Schedule
13D (or an amendment thereto) relating to the transaction contemplated by this Agreement for the Purchaser, and upon the Purchaser’s
request, any future Exchange Act Section 13 and 16 filings relating to ownership of the Shares. The Purchaser agrees to provide
the Company all information required by any such Commission filings promptly after the occurrence of the event triggering such
filing, and the Company shall use its best efforts to prepare a draft of such filing(s) for the Purchaser’s review, comment,
if any, and authorization for filing within the deadline for the applicable filing. In the event the Purchaser elects to prepare
and make such filings, the Company shall promptly cooperate with and provide the Purchaser with such information as it may reasonably
request in connection with the preparation of such filings.

 

(g)          The
Company shall, and shall cause its subsidiaries to, comply with (i) the Credit Agreement and (ii) all other contractual obligations
as such obligations become due and payable to the extent to which the failure to so comply would reasonably be expected to have
a Material Adverse Effect, unless and to the extent such obligations are being contested in good faith by appropriate proceedings
and adequate reserves (as determined in accordance with GAAP) have been established on its books and financial statements of the
Company for such obligations.

 

(h)          The
Company shall, and shall cause its subsidiaries to, pay and discharge all Taxes due and owing by the Company before the same becomes
delinquent and before penalties accrue thereon, unless and to the extent such Taxes are being contested in good faith by appropriate
procedures and adequate accruals or reserves (as determined in accordance with GAAP) have been established on the books and financial
statements of the Company for such Taxes.

 

(i)          The
Company shall, and shall cause its subsidiaries to, maintain and keep its properties and assets in good repair, working order and
condition, ordinary wear and tear excepted.

 

(j)          The
Company shall maintain with financially sound and reputable insurance companies (i) property and casualty and other insurance covering
risks and hazards of such types and in such amounts as are customary for adequately-insured companies of similar size engaged in
similar industries and lines of business, and (ii) directors and officers liability insurance on terms and conditions satisfactory
in all material respects to the Purchaser.

 

    	 	24	 

     

    

 

(k)          The
Company shall keep adequate books, accounts and records in accordance with past custom and practice as used in the preparation
of its financial statements, which books, accounts and records shall fairly present in all material respects the financial condition
and results of operations of the Company and its subsidiaries.

 

(l)          The
Company shall (i) own, exclusively or jointly with other Persons, all right, title and interest in and to, or have a valid license
for, and shall maintain all Intellectual Property necessary to the conduct of its business, free and clear of Liens, (ii) enter
into and maintain in full force and effect binding, written agreements with every current and former employee of the Company, and
with every current and former independent contractor, whereby such employees and independent contractors (A) assign to the Company
any ownership interest and right they may have in the Company’s Intellectual Property and (B) acknowledge the Company’s
exclusive ownership of all of the Company’s Intellectual Property, and (iii) remain in full compliance with all legal requirements
applicable to the Company’s Intellectual Property and the Company’s ownership and use thereof.

 

(m)          The
Company shall perform and observe all of its obligations and covenants set forth in each of the Transaction Documents.

 

ARTICLE VI

 

INDEMNIFICATION

 

6.1         Indemnification
by the Company. The Company shall indemnify, defend and hold harmless the Purchaser and its affiliates and their respective
directors, officers, members, managers, employees, representatives and agents, and their respective successors and assigns (collectively,
the “Purchaser Indemnitees”), from and against, and shall pay and reimburse each of them for, any and all losses,
claims, damages, liabilities and expenses (including, without limitation, reasonable attorney fees and disbursements and other
expenses reasonably incurred in connection with investigating, preparing or defending any Action pending or threatened and the
costs of enforcement thereof) (collectively, “Losses”) incurred or sustained by, or imposed upon, the Purchaser
Indemnitees based upon, arising out of, with respect to or by reason of:

 

(a)          any
inaccuracy in or breach of any of the representations or warranties of the Company contained in this Agreement or in any certificate
or instrument delivered by or on behalf of the Company pursuant to this Agreement; or

 

(b)          any
breach or non-fulfillment of any covenant, agreement or obligation to be performed by the Company pursuant to this Agreement.

 

    	 	25	 

     

    

 

6.2         Indemnification
Procedure. Any Purchaser Indemnitee entitled to indemnification hereunder shall (a) give prompt notice to the Company
of any claim with respect to which it seeks indemnification and (b) permit the Company to assume the defense of such claim
with counsel reasonably satisfactory to the Purchaser Indemnitee; provided that any Purchaser Indemnitee entitled to indemnification
hereunder shall have the right to employ separate counsel and to participate in the defense of such claim, but the fees and expenses
of such counsel shall be at the expense of such Purchaser Indemnitee unless (i) the Company has agreed to pay such fees or
expenses, or (ii) the Company shall have failed to assume the defense of such claim and employ counsel reasonably satisfactory
to such Purchaser Indemnitee or (iii) in the reasonable judgment of any such Purchaser Indemnitee, based upon written advice
of its counsel, a conflict of interest exists between such Purchaser Indemnitee and the Company with respect to such claims (in
which case, if the Purchaser Indemnitee notifies the Company in writing that such Purchaser Indemnitee elects to employ separate
counsel at the expense of the Company, the Company shall not have the right to assume the defense of such claim on behalf of such
Purchaser Indemnitee); and provided, further, that the failure of any Purchaser Indemnitee to give notice as provided
herein shall not relieve the Company of its obligations hereunder, except to the extent that such failure to give notice shall
materially adversely affect the Company in the defense of any such claim or litigation. The Company shall not, except with the
consent of the Purchaser Indemnitee, which consent shall not be unreasonably withheld, conditioned or delayed, consent to entry
of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by the claimant
or plaintiff to such Purchaser Indemnitee of a release from all liability in respect of such claim or litigation. No Purchaser
Indemnitee will, except with the consent of the Company, which consent shall not be unreasonably withheld, conditioned or delayed,
consent to entry of any judgment or enter into any settlement.

 

6.3         Payments.
Once a Loss is agreed to by the Company or finally adjudicated to be payable pursuant to this Article VI, the Company
shall satisfy its obligations within 15 days of such final, non-appealable adjudication by wire transfer of immediately available
funds. The parties hereto agree that should the Company not make full payment of any such obligations within such 15-day period,
any amount payable shall accrue interest from and including the date of agreement of the Company or final, non-appealable adjudication
to the date such payment has been made at a rate per annum equal to 12%.

 

ARTICLE VII

 

MISCELLANEOUS

 

7.1         Fees
and Expenses. Each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any,
and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of
this Agreement; provided, however, the Company will pay at the Closing for the reasonable and documented legal fees and expenses
of Carlton Fields Jorden Burt, P.A. incurred in connection with its role as counsel to the Purchaser in the transactions contemplated
by the Transaction Documents.

 

7.2         Entire
Agreement. This Agreement, the schedules and exhibits attached hereto, and any other documents or agreements executed in
connection with the transactions contemplated hereby, contain the entire understanding of the parties with respect to the subject
matter hereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties
acknowledge have been merged into such documents, exhibits and schedules.

 

    	 	26	 

     

    

 

7.3         Further
Assurances. At or after the Closing, and without further consideration, the Company will execute and deliver to the Purchaser
such further documents and take such further actions as may be reasonably requested in order to give practical effect to the intention
of the parties under the Transaction Documents.

 

7.4         Notices.
All notices and other communications required or permitted under this Agreement shall be in writing and shall be deemed effectively
given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed facsimile if sent during normal business
hours of the recipient, if not, then on the next business day, (c) five days after having been sent by registered or certified
mail, return receipt requested, postage prepaid, or (d) one day after deposit with a nationally recognized overnight courier, specifying
next day delivery, with written verification of receipt. The addresses and facsimile numbers for such notices and communications
are those set forth on the signature pages hereof, or such other address or facsimile number as may be designated in writing hereafter
upon five (5) days’ notice, in the same manner, by such Person.

 

7.5         Amendments;
Waivers. No provision of this Agreement may be waived or amended except in a written instrument signed, in the case of
an amendment, by the Company and the Purchaser or, in the case of a waiver, by the party against whom enforcement of any such waiver
is sought. No waiver by any party shall operate or be construed as a waiver in respect of any failure, breach or default not expressly
identified by such written waiver, whether of a similar or different character, and whether occurring before or after that waiver.
No failure to exercise, or delay in exercising, any right, remedy, power or privilege arising from this Agreement shall operate
or be construed as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder
preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege

 

7.6         Construction.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party. For purposes of this Agreement, (a)
the words “include,” “includes” and “including” shall be deemed to be followed by the words
“without limitation”; (b) the word “or” is not exclusive; and (c) the words “herein,” “hereof,”
“hereby,” “hereto” and “hereunder” refer to this Agreement as a whole. Unless the context otherwise
requires, references herein: (x) to Articles, Sections, Schedules and Exhibits mean the Articles and Sections of, and Schedules
and Exhibits attached to, this Agreement; (y) to an agreement, instrument or other document means such agreement, instrument or
other document as amended, supplemented and modified from time to time to the extent permitted by the provisions thereof and (z)
to a statute means such statute as amended from time to time and includes any successor legislation thereto and any regulations
promulgated thereunder. All terms defined in this Agreement shall have the defined meanings when used in any notice, certificate
or other document made or delivered pursuant hereto. Any noun or pronoun shall be deemed to include both the singular and the plural
and to cover all genders. Each reference in this Agreement to a Person shall be deemed to include such Person’s successors
and permitted assigns.

 

    	 	27	 

     

    

 

7.7         Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted
assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of
the Purchaser. The Purchaser may assign its rights under this Agreement to any Person to whom Purchaser assigns or transfers any
Securities, provided such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions
hereof that apply to the “Purchaser.” Notwithstanding anything to the contrary herein, Securities may be assigned to
any Person in connection with a bona fide margin account or other loan or financing arrangement secured by such Securities.

 

7.8         No
Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

7.9         Governing
Law; Venue; Waiver of Jury Trial. THE CORPORATE LAWS OF THE STATE OF DELAWARE SHALL GOVERN ALL ISSUES CONCERNING THE RELATIVE
RIGHTS OF THE COMPANY AND ITS STOCKHOLDERS. all questions concerning the construction,
validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the
laws of the state of new york. THE COMPANY AND PURCHASER Hereby Irrevocably Submit To The Exclusive Jurisdiction Of The State And
Federal Courts Sitting In The CITY OF NEW YORK, BOROUGH OF MANHATTAN, For The Adjudication Of Any Dispute BROUGHT BY THE COMPANY
OR PURCHASER Hereunder, In Connection Herewith Or With Any Transaction Contemplated Hereby Or Discussed Herein (Including With
Respect To The Enforcement Of Any Of The Transaction Documents), And Hereby Irrevocably Waive, And Agree Not To Assert In Any Suit,
Action Or ProceedinG BROUGHT BY THE COMPANY OR PURCHASER, Any Claim That It Is Not Personally Subject To The Jurisdiction Of Any
Such Court, OR That Such Suit, Action Or Proceeding Is Improper. Each party Hereby Irrevocably Waives Personal Service Of Process
And Consents To Process Being Served In Any Such Suit, Action Or Proceeding By Mailing A Copy Thereof Via Registered Or Certified
Mail Or Overnight Delivery (With Evidence Of Delivery) To Such Party At The Address In Effect For Notices To It Under This Agreement
And Agrees That Such Service Shall Constitute Good And Sufficient Service Of Process And Notice Thereof. Nothing Contained Herein
Shall Be Deemed To Limit In Any Way Any Right To Serve Process In Any Manner Permitted By Law. The Company AND PURCHASER Hereby
Waive All Rights To A Trial By Jury.

 

7.10        Survival.
The representations, warranties, agreements and covenants contained herein shall survive the Closing and the delivery and/or exercise
of the Securities, as applicable.

 

    	 	28	 

     

    

 

7.11        Execution.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being
understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile or electronic
transmission, including via PDF, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such facsimile or electronic signature page were an original
thereof.

 

7.12        Severability.
If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of the
remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt
to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate
such substitute provision in this Agreement.

 

7.13        Remedies.
In addition to being entitled to exercise all rights and remedies provided herein or granted by or available under Law, including
recovery of damages, the Purchaser and the Company will be entitled to specific performance under the Transaction Documents. The
parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations
described in the foregoing sentence and hereby agrees to waive in any action for specific performance of any such obligation (other
than in connection with any action for a temporary restraining order) the defense that a remedy at law would be adequate.

 

[Signature
pages to follow]

 

    	 	29	 

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

	 	Company:
	 	 
	 	GRANDPARENTS.COM, Inc.

 

	 	By: 	/s/ Steve Leber
	 	 	Name:  Steve Leber
	 	 	Title:    Chairman and Chief Executive Officer

 

	 	Address for Notice:
	 	Grandparents.com, Inc.
	 	589 Eighth Avenue, 6th floor
	 	New York New York 10018
	 	Telephone: (646) 839-8809
	 	Facsimile: (646) 654-6106  
	 	Attention: Chief Executive Officer
	 	 
	 	With a copy (which shall not constitute notice) to:
	 	 
	 	Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
	 	Chrysler Center
	 	666 Third Avenue
	 	New York, New York 10017
	 	Telephone: (212) 692-6223
	 	Facsimile:  (212) 983-3115
	 	Attention: Daniel I. DeWolf, Esq.

 

[Signature Page to Securities Purchase Agreement]

 

     

     

    

 

	 	PURCHASER:
	 	 
	 	VB FUNDING, LLC

 

	 	By:	/s/ Vincent J. Dowling, Jr.
	 	 	Name:  Vincent J. Dowling, Jr.
	 	 	Title:    Manager

 

	 	Address for Notice:
	 	VB Funding, LLC
	 	190 Farmington Avenue
	 	Farmington, Connecticut 06032
	 	Telephone: (860) 676-8600
	 	Facsimile: (860) 676-8617
	 	Attention: Vincent J. Dowling, Jr.
	 	 
	 	With a copy (which shall not constitute notice) to:
	 	 
	 	Carlton Fields Jorden Burt, P.A.
	 	One State Street
	 	Suite 1800
	 	Hartford, Connecticut  06103
	 	Telephone: (860) 392-5015
	 	Facsimile: (860) 392-5058
	 	Attention: Frank A. Appicelli, Esq.

 

[Signature Page to Securities Purchase Agreement]

 

     

     

    

 

EXHIBIT A

 

     

     

    

 

GRANDPARENTS.COM, INC.

 

CERTIFICATE OF
DESIGNATION, PREFERENCES AND RIGHTS

OF

SERIES D CONVERTIBLE 12% PREFERRED STOCK

 

(Pursuant to Section 151(g) of the General
Corporation Law of the State of Delaware)

 

The undersigned, being
the President of Grandparents.com, Inc. (the “Corporation”), a corporation organized and existing under the
General Corporation Law of the State of Delaware (the “DGCL”), in accordance with the provisions of Section
151(g) of the DGCL, does hereby certify that:

 

Pursuant to the authority
vested in the Board of Directors of the Corporation by the Third Amended and Restated Certificate of Incorporation of the Corporation
(the “Certificate of Incorporation”), the Board of Directors, on _______ ___, 2016, in accordance with Section
151(g) of the DGCL, duly adopted the following resolution establishing a series of 1,500,000 shares of the Corporation’s
preferred stock, par value $0.01 per share, to be designated as its Series D Convertible 12% Preferred Stock:

 

RESOLVED, that
pursuant to the authority vested in the Board of Directors by the Certificate of Incorporation of the Corporation, the Board of
Directors hereby establishes the Series D Convertible 12% Preferred Stock of the Corporation and hereby states the number of shares,
and fixes the powers, designations, preferences and relative, participating, optional and other rights, and the qualifications,
limitations and restrictions thereof, of such series of shares as follows:

 

SERIES D CONVERTIBLE 12% PREFERRED STOCK

 

Section 1.          Designation
and Number of Shares. There shall be created from the 5,000,000 shares of the Corporation’s preferred stock, par value
$0.01 per share, authorized to be issued by the Certificate of Incorporation (“Preferred Stock”), a series of
Preferred Stock designated as “Series D Convertible 12% Preferred Stock” (the “Series D Convertible Preferred
Stock”), and the authorized number of shares constituting the Series D Convertible Preferred Stock shall be 1,500,000.
Upon the unanimous written consent of the Holders of the shares of Series D Convertible Preferred Stock then outstanding, such
number of shares may be decreased by resolution of the Board of Directors adopted and filed pursuant to Section 151(g) of the DGCL,
or any successor provision, and by the filing of a certificate of decrease with the Secretary of State of the State of Delaware;
provided that no such decrease shall reduce the number of authorized shares of Series D Convertible Preferred Stock to a number
less than the number of shares then outstanding plus the number of shares reserved for issuance upon the exercise of outstanding
options, warrants, convertible or exchangeable securities or other rights to acquire shares of Series D Convertible Preferred Stock.
Each share of Series D Convertible Preferred Stock shall have a stated value equal to $0.666667 (as may be adjusted for any stock
dividends, combinations or splits with respect to such shares pursuant to Section 3(b)) (the “Stated Value”).

 

     

     

    

 

Section 2.          Certain
Definitions. As used herein, the following terms have the following meanings:

 

“Board of
Directors” shall mean the Board of Directors of the Corporation or, with respect to any action to be taken by the Board
of Directors, any committee of the Board of Directors duly authorized to take such action.

 

“Business
Day” means any day other than Saturday, Sunday, any day which shall be a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to
close.

 

“Certificate
of Designation” shall mean the Certificate of Designation filed with the Secretary of State of the State of Delaware
fixing the powers, designations, preferences and relative, participating, optional and other rights, and the qualifications, limitations
and restrictions thereof, of the Series D Convertible Preferred Stock.

 

“Certificate
of Incorporation” shall mean the Third Amended and Restated Certificate of Incorporation of the Corporation, as may be
amended and/or restated from time to time.

 

“Common Stock”
means the Corporation’s common stock, par value $0.01 per share.

 

“Deemed Liquidation
Event” shall mean (i) a merger or consolidation in which (x) the Corporation is a constituent party or (y) a subsidiary
of the Corporation is a constituent party and the Corporation issues shares of its capital stock pursuant to such merger or consolidation,
except any such merger or consolidation involving the Corporation or a subsidiary in which the share capital stock of the Corporation
outstanding immediately prior to such merger or consolidation continue to represent, or are converted into or exchanged for shares
of capital stock that represent, immediately following such merger or consolidation, at least a majority, by voting power, of the
capital stock of (a) the surviving or resulting corporation; or (b) if the surviving or resulting corporation is a wholly owned
subsidiary of another corporation immediately following such merger or consolidation, the parent corporation of such surviving
or resulting corporation; or (ii) the sale, lease, transfer, exclusive license or other disposition, in a single transaction or
series of related transactions, by the Corporation or any subsidiary of the Corporation of all or substantially all of the assets
of the Corporation and its subsidiaries taken as a whole or the sale or disposition (whether by merger, consolidation or otherwise)
of one or more subsidiaries of the Corporation if substantially all of the assets of the Corporation and its subsidiaries taken
as a whole are held by such subsidiary or subsidiaries, except where such sale, lease, transfer, exclusive license or other disposition
is to a wholly owned subsidiary of the Corporation.

 

“Holder”
shall mean a holder of record of the Series D Convertible Preferred Stock.

 

“Junior Securities”
shall mean the Corporation’s Common Stock, the Corporation’s Series C Redeemable Convertible 7.5% Preferred Stock and
any other class or series of capital stock (including Preferred Stock) of the Corporation hereafter created or specifically designated
as junior to the Series D Convertible Preferred Stock.

 

    	 	2	 

     

    

 

“Original
Issue Date” shall mean the date of the first issuance of any shares of the Series D Convertible Preferred Stock regardless
of the number of transfers of any particular shares of Series D Convertible Preferred Stock and regardless of the number of certificates
which may be issued to evidence such Series D Convertible Preferred Stock.

 

“Person” means
an individual, corporation, partnership, joint venture, limited liability company, governmental authority, unincorporated organization,
trust, association or other entity.

 

“Trading Day”
shall mean (i) a day on which the Common Stock is traded on a Trading Market (other than the OTCQB), or (ii) if the Common Stock
is not listed or quoted on a Trading Market (other than the OTCQB), a day on which the Common Stock is traded in the over-the-counter
market, as reported by the OTCQB, or (iii) if the Common Stock is not listed or quoted on any Trading Market, a day on which the
Common Stock is quoted in the over-the-counter market as reported by the OTCPink (Current Information) tier of OTC Markets Group,
Inc. (or any similar organization or agency succeeding to its functions of reporting prices); provided, that in the event that
the Common Stock is not listed or quoted as set forth in (i), (ii) and (iii) hereof, then Trading Day shall mean a Business Day.

 

“Trading Market”
shall mean whichever of the New York Stock Exchange, the NASDAQ Global Select Market, the NASDAQ Global Market, the NASDAQ
Capital Market, OTCQX or OTCQB on which the Common Stock is listed or quoted for trading on the date in question.

 

Section 3.          Dividends.
There will be no dividends due or payable on the Series D Convertible Preferred Stock other than as set forth in this Section
3.

 

(a)        Accruing
Dividends. From and after the date of the issuance of any shares of Series D Convertible Preferred Stock, dividends at the
rate per annum of 12% of the Stated Value per share, plus all unpaid accrued and accumulated dividends thereon, shall accrue on
such shares of Series D Convertible Preferred Stock (subject to appropriate adjustment in the event of any stock dividend, stock
split, combination or other similar recapitalization with respect to the Series D Convertible Preferred Stock) (the “Accruing
Dividends”).  The Accruing Dividends shall be cumulative and accrue on a per annum basis, whether or not declared
and whether or not there are funds legally available for the payment of dividends, and shall be payable in cash on a quarterly
basis.  Such Accruing Dividends shall be declared (or deemed declared) by the Board of Directors on a quarterly basis;
however, the Accruing Dividend shall be paid only out of legally available funds therefor.  To the extent not paid on
the last day of March, June, September and December of each calendar year, all Accruing Dividends on any share of Series D Convertible
Preferred Stock shall accumulate whether or not declared by the Board of Directors and shall remain accumulated dividends until
paid pursuant hereto. All accrued and accumulated dividends on the Shares shall be prior and in preference to any dividend on any
Junior Securities and shall be fully declared and paid before any dividends are declared and paid, or any other distributions or
redemptions are made, on any Junior Securities. All accrued and unpaid Accruing Dividends shall be paid upon a Liquidation Event
pursuant to Section 4, conversion pursuant to Section 5 or redemption pursuant to Section 8.  

 

    	 	3	 

     

    

 

(b)           Participating
Dividends. In addition to the Accruing Dividends on the Series D Convertible Preferred Stock pursuant to Section 3(a)
hereof, the Corporation shall not declare, pay or set aside any dividends on shares of any other class or series of capital stock
of the Corporation unless (in addition to the obtaining of any consents required elsewhere in the Certificate of Incorporation)
the Holders of the Series D Convertible Preferred Stock then outstanding shall first receive a dividend on each outstanding share
of Series D Convertible Preferred Stock in an amount at least equal to (i) in the case of a dividend on Common Stock or any class
or series that is convertible into Common Stock, that dividend per share of Series D Convertible Preferred Stock as would equal
the product of (x) the dividend payable on each share of such class or series determined, if applicable, as if all shares of such
class or series had been converted into Common Stock and (y) the number of shares of Common Stock issuable upon conversion of a
share of Series D Convertible Preferred Stock, in each case calculated on the record date for determination of holders entitled
to receive such dividend or (ii) in the case of a dividend on any class or series that is not convertible into Common Stock, at
a rate per share of Series D Convertible Preferred Stock determined by (x) dividing the amount of the dividend payable on each
share of such class or series of capital stock by the original issuance price of such class or series of capital stock (subject
to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect
to such class or series) and (y) multiplying such fraction by an amount equal to the Stated Value.

 

(c)          Partial
Dividend Payments. Except as otherwise provided herein, if at any time the Corporation pays less than the total amount of dividends
then accrued and accumulated with respect to the Series D Convertible Preferred Stock, such payment shall be distributed pro rata
among the Holders thereof based upon the aggregate accrued and accumulated but unpaid dividends on the shares of Series D Convertible
Preferred Stock held by each such Holder.

 

Section 4.            Liquidation;
Winding Up, Bankruptcy.

 

(a)          Preferential
Payments to Holders of Series D Convertible Preferred Stock.  In the event of any voluntary or involuntary liquidation,
dissolution or winding up of the Corporation or Deemed Liquidation Event (each, a “Liquidation Event”), the
Holders of shares of Series D Convertible Preferred Stock then outstanding shall be entitled to be paid out of the assets of the
Corporation available for distribution to its stockholders before any payment shall be made to the holders of Junior Securities
by reason of their ownership thereof, an amount in cash equal to the Stated Value per share, plus any Accruing Dividends accrued
and accumulated but unpaid thereon, whether or not declared, together with any other dividends declared but unpaid thereon (the
amount payable pursuant to this sentence is hereinafter referred to as the “Series D Liquidation Amount”).   If
upon any such Liquidation Event, the assets of the Corporation available for distribution to its stockholders shall be insufficient
to pay the Holders of shares of Series D Convertible Preferred Stock the full amount to which they shall be entitled under this
Section 4(a), (i) the Holders of shares of Series D Convertible Preferred Stock shall share ratably in any distribution
of the assets available for distribution in proportion to the respective amounts which would otherwise be payable in respect of
the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid in full, and
(ii) the Corporation shall not make or agree to make any payments to the holders of Junior Securities.

 

    	 	4	 

     

    

 

(b)          Notice
of Liquidation Event. In the event of any Liquidation Event, the Corporation shall, within ten (10) days of the date the Board
of Directors approves such action, or no later than twenty (20) days of any stockholders’ meeting called to approve such
action, or within twenty (20) days of the commencement of any involuntary proceeding, whichever is earlier, give each Holder of
shares of Series D Convertible Preferred Stock written notice of the proposed action. Such written notice shall describe the material
terms and conditions of such proposed action, including a description of the stock, cash and property to be received by the Holders
of shares of Series D Convertible Preferred Stock upon consummation of the proposed action and the date of delivery thereof. If
any material change in the facts set forth in the initial notice shall occur, the Corporation shall promptly give written notice
to each Holder of such material change.

 

(c)          Liquidation
Events.

 

(i)          Effecting
a Deemed Liquidation Event.  In the event of a Deemed Liquidation Event referred to in Section 4(a) or 4(b),
if the Corporation does not effect a dissolution of the Corporation under the DGCL within ninety (90) days after such Deemed Liquidation
Event, then (i) the Corporation shall send a written notice to each Holder of Series D Convertible Preferred Stock no later than
the ninetieth (90th) day after the Deemed Liquidation Event advising such Holders of their right (and the requirements
to be met to secure such right) pursuant to the terms of the following clause; (ii) to require the redemption of such shares of
Series D Convertible Preferred Stock; and (iii) if the Holders of at least 50% of the then outstanding shares of Series D Convertible
Preferred Stock so request in a written instrument delivered to the Corporation not later than one hundred twenty (120) days after
such Deemed Liquidation Event, the Corporation shall use the consideration received by the Corporation for such Deemed Liquidation
Event (net of any retained liabilities associated with the assets sold or technology licensed, as determined in good faith by the
Board of Directors of the Corporation), together with any other assets of the Corporation available for distribution to its stockholders,
all to the extent permitted by Delaware law governing distributions to stockholders (the “Available Proceeds”),
on the one hundred fiftieth (150th) day after such Deemed Liquidation Event, to redeem all outstanding shares of Series
D Convertible Preferred Stock at a price per share equal to the Series D Liquidation Amount.  Notwithstanding the foregoing,
in the event of a redemption pursuant to the preceding sentence, if the Available Proceeds are not sufficient to redeem all outstanding
shares of Series D Convertible Preferred Stock, the Corporation shall ratably redeem each Holder’s shares of Series D Convertible
Preferred Stock to the fullest extent of such Available Proceeds, and shall redeem the remaining shares as soon as it may lawfully
do so under Delaware law governing distributions to stockholders.  The provisions of Section 8 shall apply, with
such necessary changes in the details thereof as are necessitated by the context, to the redemption of the Series D Convertible
Preferred Stock pursuant to this Section 4(c).   Prior to the distribution or redemption provided for in
this Section 4(c), the Corporation shall not expend or dissipate the consideration received for such Deemed Liquidation
Event, except to discharge expenses incurred in connection with such Deemed Liquidation Event or in the ordinary course of business.

 

    	 	5	 

     

    

 

(ii)         Amount
Deemed Paid or Distributed. The amount deemed paid or distributed to the holders of capital stock of the Corporation upon any
such merger, consolidation, sale, transfer, exclusive license, other disposition or redemption shall be the cash or the value of
the property, rights or securities paid or distributed to such holders by the Corporation or the acquiring Person.  The
value of such property, rights or securities shall be determined in good faith by the Board of Directors of the Corporation.

 

Section 5.            Conversion
Rate; Adjustments; Conversion.

 

(a)          Optional
Conversion. The Holders of the Series D Convertible Preferred Stock shall have conversion rights as follows (the “Conversion
Rights”):

 

(i)          Right
to Convert.

 

a.           Conversion
Ratio. Each share of Series D Convertible Preferred Stock shall be convertible, at the option of the Holder thereof, at any
time and from time to time and after the Original Issue Date, and without the payment of additional consideration by the Holder
thereof, into 1,222 fully paid and non-assessable shares of Common Stock (the “Preferred Share Conversion Rate”),
which shall be subject to adjustment as provided in Section 5(b) in order to prevent any dilution of the conversion rights
granted under this Section 5. As used herein “fully-diluted basis” means, at any applicable point in time, the
issued and outstanding shares of Common Stock of the Corporation, on a fully-diluted basis, after giving effect to (i) all issued
and outstanding shares of Common Stock, (ii) the conversion into Common Stock of all issued and outstanding shares of Series D
Convertible Preferred Stock, (iii) all shares of Common Stock issuable upon exercise of any outstanding options, warrants or other
rights to purchase Common Stock, and (iv) all shares of Common Stock issuable upon conversion of any outstanding notes, debentures,
all other classes of preferred stock, or other securities convertible into or exchangeable for shares of Common Stock.

 

b.           Termination
of Conversion Rights. In the event of a notice of redemption of any shares of Series D Convertible Preferred Stock pursuant
to Section 8, the Conversion Rights of the shares designated for redemption shall terminate at the close of business on
the last full day preceding the date fixed for redemption, unless the redemption price is not fully paid on such redemption date,
in which case the Conversion Rights for such shares shall continue until such price is paid in full. In the event of a Liquidation
Event, the Conversion Rights shall terminate at the close of business on the last full day preceding the date fixed for the payment
of any such amounts distributable on such event to the Holders of Series D Convertible Preferred Stock.

 

    	 	6	 

     

    

 

(ii)         Notice
of Conversion. In order for a Holder of Series D Convertible Preferred Stock to voluntarily convert shares of Series D Convertible
Preferred Stock into shares of Common Stock, such Holder shall (i) provide ten (10) days prior written notice to the Corporation’s
transfer agent at the office of the transfer agent for the Series D Convertible Preferred Stock (or at the principal office of
the Corporation if the Corporation serves as its own transfer agent) that such Holder elects to convert all or any number of such
Holder’s shares of Series D Convertible Preferred Stock and, if applicable, any event on which such conversion is contingent
and (ii) if such Holder’s shares are certificated, surrender the certificate or certificates for such shares of Series D
Convertible Preferred Stock (or, if such registered Holder alleges that such certificate has been lost, stolen or destroyed, a
lost certificate affidavit and agreement reasonably acceptable to the Corporation to indemnify the Corporation against any claim
that may be made against the Corporation on account of the alleged loss, theft or destruction of such certificate), at the office
of the transfer agent for the Series D Convertible Preferred Stock (or at the principal office of the Corporation if the Corporation
serves as its own transfer agent).  Such notice shall state such Holder’s name or the names of the nominees in
which such Holder wishes the shares of Common Stock to be issued.  If required by the Corporation, any certificates surrendered
for conversion shall be endorsed or accompanied by a written instrument or instruments of transfer, in form satisfactory to the
Corporation, duly executed by the registered Holder or his, her or its attorney duly authorized in writing.  The close
of business on the date of receipt by the transfer agent (or by the Corporation if the Corporation serves as its own transfer agent)
of such notice and, if applicable, certificates (or lost certificate affidavit and agreement) shall be the time of conversion (the
“Conversion Time”), and the shares of Common Stock issuable upon conversion of the specified shares shall be
deemed to be outstanding of record as of such date.  The Corporation shall, promptly after the Conversion Time (A) issue
and deliver to such Holder of Series D Convertible Preferred Stock, or to his, her or its nominees, a notice of issuance of uncertificated
shares and may, upon written request, issue and deliver a certificate for the number of full shares of Common Stock issuable upon
such conversion in accordance with the provisions hereof and, may, if applicable and upon written request, issue and deliver a
certificate for the number (if any) of the shares of Series D Convertible Preferred Stock represented by any surrendered certificate
that were not converted into Common Stock, and (B) pay any Accruing Dividends accrued but unpaid, whether or not declared, together
with any other dividends declared but unpaid, on the shares of Series D Convertible Preferred Stock converted. All shares of Common
Stock issued hereunder by the Corporation shall be duly and validly issued, fully paid and nonassessable, free and clear of all
taxes, liens, charges and encumbrances with respect to the issuance thereof.

 

(iii)        Effect
of Conversion.  All shares of Series D Convertible Preferred Stock which shall have been surrendered for conversion
as herein provided shall no longer be deemed to be outstanding and all rights with respect to such shares shall immediately cease
and terminate at the Conversion Time, except only the right of the Holders thereof to receive shares of Common Stock in exchange
therefor and to receive payment of any Accruing Dividends accrued but unpaid, whether or not declared thereon, or any dividends
declared but unpaid thereon.  Any shares of Series D Convertible Preferred Stock so converted shall be retired and cancelled
and may not be reissued as shares of such series, and the Corporation may thereafter take such appropriate action (without the
need for stockholder action) as may be necessary to reduce the authorized number of shares of Series D Convertible Preferred Stock
accordingly.

 

    	 	7	 

     

    

 

(iv)        No
Further Adjustment.  Upon any such conversion, no adjustment to the Preferred Share Conversion Rate shall be made
for any declared but unpaid dividends on the Series D Convertible Preferred Stock surrendered for conversion or on the Common Stock
delivered upon conversion.

 

(v)         Taxes.  The
Corporation shall pay any and all issue and other similar taxes that may be payable in respect of any issuance or delivery of shares
of Common Stock upon conversion of shares of Series D Convertible Preferred Stock pursuant to this Section 5.  

 

(vi)        Reservation
of Stock. The Corporation shall, at all times while any shares of Series D Convertible Preferred Stock are outstanding, reserve
and keep available out of its authorized but unissued shares of capital stock, solely for the purpose of issuance upon the conversion
of the Series D Convertible Preferred Stock, such number of shares of Common Stock issuable upon the conversion of all outstanding
Series D Convertible Preferred Stock pursuant to this Section 5, taking into account any adjustment to such number of shares
so issuable in accordance with Section 5(b) hereof. The Corporation shall take all such actions as may be necessary to assure
that all such shares of Common Stock may be so issued without violation of any applicable law or governmental regulation or any
requirements of any Trading Market (except for official notice of issuance which shall be immediately delivered by the Corporation
upon each such issuance). The Corporation shall not close its books against the transfer of any of its capital stock in any manner
which would prevent the timely conversion of the shares of Series D Convertible Preferred Stock.

 

(b)          Adjustments
to Preferred Share Conversion Rate.

 

(i)          If
the Corporation, at any time while any shares of Series D Convertible Preferred Stock are outstanding, shall (i) issue, grant or
sell any shares of Common Stock or any securities convertible into or exercisable for any class or series of capital stock of the
Corporation, (ii) pay a stock dividend or otherwise make a distribution or distributions on shares of its Common Stock payable
in shares of its capital stock (whether payable in shares of its Common Stock or of capital stock of any class), (iii) subdivide
outstanding shares of Common Stock into a larger number of shares, (iv) combine outstanding shares of Common Stock into a smaller
number of shares, (v) issue by reclassification of shares of Common Stock any shares of capital stock of the Corporation, (vi)
effect a capital reorganization of the Corporation, (vii) effect a Deemed Liquidation Event, or (viii) effect another similar transaction
(including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features),
then the Board of Directors shall make an appropriate adjustment in the Preferred Share Conversion Rate designated in Section
5(a) hereof so that at all times all shares of Series D Convertible Preferred Stock shall be convertible into that amount of
the then issued and outstanding shares Common Stock, on a fully-diluted basis, necessary for the Holder to maintain its ownership
of the Corporation consistent with the terms of Section 5(a)(i)a. hereof. Any adjustment made pursuant to this Section
5(b)(i) shall become effective immediately after the record date for the determination of stockholders entitled to receive
such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination,
reclassification, reorganization, Deemed Liquidation Event or other similar transaction.

 

    	 	8	 

     

    

 

(ii)         All
calculations under this Section 5(b) shall be made to the nearest 1/1,000th of a cent or the nearest 1/1,000th
of a share, as the case may be. Any calculation resulting in a fraction shall be rounded up to the next cent or share.

 

(iii)        Whenever
the Preferred Share Conversion Rate is adjusted pursuant to Section 5(b)(i), the Corporation shall within ten (10) days
after the determination of the new Preferred Share Conversion Rate deliver to each Holder at such Holder’s last address as
it shall appear upon the Series D Convertible Preferred Stock register a notice setting forth the new Preferred Share Conversion
Rate after such adjustment and setting forth a brief statement of the facts requiring such adjustment.

 

(iv)        In
case of any reclassification of the Common Stock, any consolidation or merger of the Corporation with or into another Person, the
sale or transfer of all or substantially all of the assets of the Corporation or any compulsory share exchange pursuant to which
the Common Stock is converted into other securities, cash or property, then each Holder shall have the right thereafter to convert
such Series D Convertible Preferred Stock only into the shares of stock and other securities and property receivable upon or deemed
to be held by holders of Common Stock following such reclassification, consolidation, merger, sale, transfer or share exchange
(except in the event the property is cash, then such Holder shall have the right to convert the Series D Convertible Preferred
Stock and receive cash in the same manner as other stockholders), and such Holder shall be entitled upon such event to receive
such amount of securities or property as the shares of the Common Stock into which such Series D Convertible Preferred Stock could
have been converted immediately prior to such reclassification, consolidation, merger, sale, transfer or share exchange would have
been entitled. The terms of any such consolidation, merger, sale, transfer or share exchange shall include such terms so as to
continue to give to the Holder the right to receive the securities or property set forth in this Section 5(b)(iv) upon any
conversion following such consolidation, merger, sale, transfer or share exchange. This provision shall similarly apply to successive
reclassifications, consolidations, mergers, sales, transfers or share exchanges.

 

(v)         If
(i) the Corporation shall declare a dividend (or any other distribution) on its Common Stock; (ii) the Corporation shall declare
a special nonrecurring cash dividend on or a redemption of its Common Stock; (iii) the approval of any stockholders of the Corporation
shall be required in connection with any reclassification of the Common Stock (other than a subdivision or combination of the outstanding
shares of Common Stock), any consolidation or merger to which the Corporation is a party, any sale or transfer of all or substantially
all of the assets of the Corporation, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property; or (iv) the Corporation shall authorize the voluntary or involuntary dissolution, liquidation or winding-up of
the affairs of the Corporation, then the Corporation shall cause to be filed at each office or agency maintained for the purpose
of conversion of Series D Convertible Preferred Stock, and shall cause to be delivered to each Holder at such Holder’s last
address as it shall appear upon the Series D Convertible Preferred Stock register, at least ten (10) calendar days prior to the
applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the
purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which
the holders of Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be
determined, or (y) the date on which such reclassification, consolidation, merger, sale, transfer, share exchange, dissolution,
liquidation or winding-up is expected to become effective, and the date as of which it is expected that holders of Common Stock
of record shall be entitled to exchange their shares of Common Stock for securities or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer, share exchange, dissolution, liquidation or winding-up; provided, however,
that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate
action required to be specified in such notice.

 

    	 	9	 

     

    

 

Section 6.            Rank.
The Series D Convertible Preferred Stock shall, as to distribution of assets upon liquidation, dissolution or winding up or a Deemed
Liquidation Event of the Corporation (whether voluntary or involuntary), rank (i) prior and senior to any Junior Securities; and
(ii) pari passu with other Series D Convertible Preferred Stock.

 

Section 7.            Voting
Rights.

 

(a)          Generally.
Except as otherwise provided herein, each Holder of outstanding shares of Series D Convertible Preferred Stock shall be entitled
to vote with holders of outstanding shares of Common Stock, voting together as a single class, with respect to any and all matters
presented to the stockholders of the Corporation for their action or consideration (whether at a meeting of stockholders of the
Corporation. In any such vote, each share of Series D Convertible Preferred Stock shall be entitled to a number of votes equal
to the number of shares of Common Stock into which the share is convertible pursuant to Section 5 hereof as of the record
date for such vote or written consent or, if there is no specified record date, as of the date of such vote or written consent.
Each Holder shall be entitled to notice of all stockholder meetings (or requests for written consent) in accordance with the Corporation’s
bylaws.

 

(b)          Election
of Directors. In the election of directors of the Corporation, the Holders of outstanding shares of Series D Convertible Preferred
Stock, voting as a separate class, shall be entitled to elect by majority vote (with each share of Series D Convertible Preferred
Stock entitled to one vote) five (5) of the seven (7) members of the Board of Directors (each, a “Series D Director”).
A Series D Director may be removed at any time as a director (with or without cause) upon, and only upon, the written request of
the Holders of the outstanding shares of Series D Convertible Preferred Stock (voting as a separate class by majority vote with
each share of Series D Convertible Preferred Stock entitled to one vote). In the event that a vacancy is created on the Board of
Directors at any time due to the death, disability, retirement, resignation or removal of a Series D Director, then the Holders
of the outstanding shares of Series D Convertible Preferred Stock (voting as a separate class by majority vote with each Share
of Series D Convertible Preferred Stock entitled to one vote) shall have the right to designate an individual to fill such vacancy.
In the event that the Holders of shares of Series D Convertible Preferred Stock shall fail to designate in writing a representative
to fill the vacant Series D Director seat on the Board of Directors, such board seat shall remain vacant until such time as the
Holders elect an individual to fill such seat in accordance with this Section 7(b), and during any period where such seat
remains vacant, the Board of Directors nonetheless shall be deemed duly constituted.

 

    	 	10	 

     

    

 

(c)          Other
Special Voting Rights. Without the prior written consent of Holders of not less than two-thirds of the then total outstanding
shares of Series D Convertible Preferred Stock, voting separately as a single class with one vote per share, in person or by proxy,
either in writing without a meeting or at an annual or a special meeting of such Holders, and any other applicable stockholder
approval requirements required by law, the Corporation shall not take, and shall cause its subsidiaries not to take or consummate,
any of the actions or transactions described in this Section 7(c) (any such action or transaction without such prior written
consent being null and void and of no force or effect) as follows:

 

(i)          create,
or authorize the creation of, any additional class or series of capital stock of the Corporation (or any security convertible into
or exercisable for any class or series of capital stock of the Corporation) or issue or sell, or obligate itself to issue or sell,
any securities of the Corporation or any subsidiary (or any security convertible into or exercisable for any class or series of
capital stock of the Corporation or any subsidiary), including any class or series of capital stock of the Corporation that ranks
superior to or in parity with the Series D Convertible Preferred Stock in rights, preferences or privileges (including with respect
to dividends, liquidation, redemption or voting) including, without limitation, any additional shares of Series C Redeemable Convertible
7.5% Preferred Stock;

 

(ii)         modify
or amend the terms of any outstanding options, warrants or other securities convertible into or exercisable for any class or series
of capital stock of the Corporation;

 

(iii)        increase
or decrease the number of authorized shares of any series of Preferred Stock or authorize the issuance of or issue any shares of
Preferred Stock;

 

(iv)        other
than as contemplated by this Certificate of Designation, amend, alter, modify or repeal the Certificate of Incorporation, this
Certificate of Designation or the by-laws of the Corporation, including the amendment of the Certificate of Incorporation by the
adoption or amendment of any Certificate of Designation or similar document, or amend the organizational documents of any subsidiary;

 

(v)         issue,
or cause any subsidiary of the Corporation to issue, any indebtedness or debt security, other than trade accounts payable and/or
letters of credit, performance bonds or other similar credit support incurred in the ordinary course of business, or amend, renew,
increase or otherwise alter in any material respect the terms of any indebtedness previously approved or required to be approved
by the Holders of the Series D Convertible Preferred Stock;

 

(vi)        increase
the authorized number of directors constituting the Board of Directors from seven (7);

 

    	 	11	 

     

    

 

(vii)       redeem,
purchase or otherwise acquire or pay or declare any dividend or other distribution on (or pay into or set aside for a sinking fund
for any such purpose) any capital stock of the Corporation; provided, that this restriction shall not apply to the redemption
or repurchase of or the payment of dividends on shares of Series D Convertible Preferred Stock pursuant hereto;

 

(viii)      declare
bankruptcy, dissolve, liquidate or wind up the affairs of the Corporation or any subsidiary of the Corporation;

 

(ix)         effect,
or enter into any agreement to effect, a Deemed Liquidation Event;

 

(x)          modify
or change the nature of the Corporation’s business as presently conducted;

 

(xi)         acquire,
or cause a subsidiary of the Corporation to acquire, in any transaction or series of related transactions, the stock or any material
assets of another Person, or enter into any joint venture with any other Person;

 

(xii)        sell,
transfer, license, lease or otherwise dispose of, in any transaction or series of related transactions, any assets of the Corporation
or any subsidiary outside the ordinary course of business;

 

(xiii)       use,
or permit the use of, the proceeds from the sale of the Series D Convertible Preferred Stock other than fund to the Corporation’s
operations and for the payment of fees and expenses associated with the issuance of the Series D Convertible Preferred Stock;

 

(xiv)      enter
into, or become subject to, any agreement or instrument or other obligation which by its terms restricts the Corporation’s
ability to perform its obligations under this Certificate of Designation, including the ability of the Corporation to pay dividends
or make any redemption or other liquidation payment required hereunder; or

 

(xv)       agree
or commit to do any of the foregoing.

 

Section 8.            Redemption
of Series D Convertible Preferred Stock.

 

(a)          Redemption
Right.  At any time and from time to time on or after the Original Issue Date, any Holder of Series D Convertible
Preferred Stock shall have the right to elect to have, out of funds legally available therefor, all or any portion of the then
outstanding shares of Series D Convertible Preferred Stock redeemed by the Corporation (a “Series D Redemption”)
for a price per share equal to the Stated Value for such share, plus all unpaid accrued and accumulated dividends on such share
(whether or not declared) (the “Series D Redemption Price”). Any such Series D Redemption shall occur not more
than sixty (60) days following receipt by the Corporation of a written election notice (the “Series D Election Notice”)
from any Holder of Series D Convertible Preferred Stock, stating the aggregate number of shares to be redeemed. Upon receipt of
a Series D Election Notice, all Holders of Series D Convertible Preferred Stock shall be deemed to have elected to have all, or
in the case of an election to redeem less than all of the shares of Series D Convertible Preferred Stock, the same pro rata
portion of their shares redeemed pursuant to this Section 8 and such election shall bind all Holders; provided, that
notwithstanding anything to the contrary contained herein, each Holder shall have the right to elect prior to the Series D Conversion
Election Date to give effect to the conversion rights contained in Section 5 instead of giving effect to the provisions
contained in this Section 8 with respect to the shares of Series D Convertible Preferred Stock held by such Holder. In exchange
for the surrender to the Corporation by the electing Holders of their certificate or certificates representing their shares of
Series D Convertible Preferred Stock in accordance with Section 8(d) below, the aggregate Series D Redemption Price for
all shares held by each such Holder shall be payable in cash in immediately available funds to the respective Holders of the Series
D Convertible Preferred Stock being redeemed on the applicable Series D Redemption Date and the Corporation shall contribute all
of its assets to the payment of the Series D Redemption Price, and to no other corporate purpose, except to the extent prohibited
by applicable Delaware law.

 

    	 	12	 

     

    

 

(b)          Redemption
Notice. As promptly as practicable, but in no event later than ten (10) days, following receipt of a Series D Election Notice,
the Corporation shall send written notice (the “Series D Redemption Notice”) of its receipt of a Series D Election
Notice to each Holder of record of Series D Convertible Preferred Stock. Each Series D Redemption Notice shall state:

 

(i)          the
number of Shares of Series D Convertible Preferred Stock held by the Holder that the Corporation shall redeem on the Series D Redemption
Date specified in the Series D Redemption Notice;

 

(ii)         the
date of the closing of the redemption, which shall be no later than sixty (60) days following receipt by the Corporation of the
Series D Election Notice (the applicable date, the “Series D Redemption Date”) and the Series D Redemption Price;

 

(iii)        the
date upon which the Holder’s right to convert its shares of Series D Convertible Preferred Stock pursuant to Section 5
terminates, which date shall be no earlier than five (5) days before the Series D Redemption Date (the applicable date, the “Series
D Conversion Election Date”); and

 

(iv)        the
manner and place designated for surrender by the Holder to the Corporation of his, her or its certificate or certificates representing
the shares of Series D Convertible Preferred Stock to be redeemed.

 

(c)          Insufficient
Funds; Remedies For Nonpayment.

 

(i)          Insufficient
Funds. If on any Series D Redemption Date, the assets of the Corporation legally available are insufficient to pay the full
Series D Redemption Price for the total number of shares elected to be redeemed pursuant to this Section 8, the Corporation
shall (A) take all appropriate action reasonably within its means to maximize the assets legally available for paying the Series
D Redemption Price, (B) redeem out of all such assets legally available therefor on the applicable Series D Redemption Date the
maximum possible number of shares of Series D Convertible Preferred Stock that it can redeem on such date, pro rata 
among the Holders of such shares to be redeemed in proportion to the aggregate number of shares elected to be redeemed by each
such Holder on the applicable Series D Redemption Date and (C) following the applicable Series D Redemption Date, at any time and
from time to time when additional assets of the Corporation become legally available to redeem the remaining shares of Series D
Convertible Preferred Stock, the Corporation shall immediately use such assets to pay the remaining balance of the aggregate applicable
Series D Redemption Price.

 

    	 	13	 

     

    

 

(ii)         Remedies
For Nonpayment. If on any Series D Redemption Date, all of the shares of Series D Convertible Preferred Stock elected to be
redeemed pursuant to a Series D Election Notice are not redeemed in full by the Corporation by paying the entire Series D Redemption
Price, until such shares are fully redeemed and the aggregate Series D Redemption Price paid in full, (A) all of the unredeemed
shares of Series D Convertible Preferred Stock shall remain outstanding and continue to have the rights, preferences and privileges
expressed herein, including the accrual and accumulation of dividends thereon and (B) the Holders of the unredeemed shares of Series
D Convertible Preferred Stock shall have all remedies available under applicable law arising from the Corporation’s breach.

 

(d)          Surrender
of Certificates. On or before the Series D Redemption Date, each Holder of Shares of Series D Convertible Preferred Stock not
otherwise electing prior to the Series D Conversion Election Date to convert its shares pursuant to Section 5 shall surrender
the certificate or certificates representing such shares to the Corporation, in the manner and place designated in the Series D
Redemption Notice, duly assigned or endorsed for transfer to the Corporation (or accompanied by duly executed stock powers relating
thereto), or, in the event the certificate or certificates are lost, stolen or missing, shall deliver an affidavit of loss, in
the manner and place designated in the Series D Redemption Notice. Each surrendered certificate shall be canceled and retired and
the Corporation shall thereafter make payment of the applicable Series D Redemption Price by certified check or wire transfer to
the Holder of record of such certificate; provided, that if less than all the shares of Series D Convertible Preferred Stock
represented by a surrendered certificate are redeemed, then a new stock certificate representing the unredeemed shares shall be
issued in the name of the applicable Holder of record of canceled stock certificate.

 

(e)          Rights
Subsequent to Redemption. If on the applicable Series D Redemption Date, the Series D Redemption Price is paid (or tendered
for payment) for any of the shares of Series D Convertible Preferred Stock to be redeemed on such Series D Redemption Date, then
on such date all rights of the Holder in the shares so redeemed and paid or tendered, including any rights to dividends on such
shares, shall cease, and such shares shall no longer be deemed issued and outstanding.

 

Section 9.            Covenants.

 

(a)          So
long as any shares of Series D Convertible Preferred Stock are outstanding, the Corporation shall not, without first obtaining
the unanimous written consent of the Holders, alter or change the rights, preferences or privileges of the Series D Convertible
Preferred Stock so as to affect adversely the Holders.

 

    	 	14	 

     

    

 

(b)          So
long as any shares of Series D Convertible Preferred Stock are outstanding, the Corporation shall not, without first obtaining
the approval of holders of a majority of the outstanding shares of Common Stock (voting as a separate class, without the vote of
Holders of the Series D Convertible Preferred Stock or any other series of Preferred Stock), alter or change the rights, preferences
or privileges of the Series D Convertible Preferred Stock.

 

Section 10.           Miscellaneous.

 

(a)          Status
of Converted or Redeemed Stock. Any shares of Series D Convertible Preferred Stock that are redeemed, converted or otherwise
acquired by the Corporation or any of its subsidiaries shall be automatically and immediately cancelled and retired and shall not
be reissued, sold or transferred. Neither the Corporation nor any of its subsidiaries may exercise any voting or other rights granted
to the Holders of Series D Convertible Preferred Stock following redemption.

 

(b)          Lost
or Stolen Certificates. Upon receipt by the Corporation of (i) evidence of the loss, theft, destruction or mutilation of any
stock certificate(s) representing shares of Series D Convertible Preferred Stock, or (ii) in the case of loss, theft or destruction,
indemnity (with a bond or other security) reasonably satisfactory to the Corporation, or in the case of mutilation, the stock certificate(s)
representing shares of Series D Convertible Preferred Stock (surrendered for cancellation), the Corporation shall execute and deliver
new stock certificate(s) representing shares of Series D Convertible Preferred Stock. However, the Corporation shall not be obligated
to reissue such lost, stolen, destroyed or mutilated stock certificate(s) representing shares of Series D Convertible Preferred
Stock if the Holder of such shares of Series D Convertible Preferred Stock contemporaneously requests the Corporation to convert
such shares of Series D Convertible Preferred Stock.

 

(c)          Notices.
Except as otherwise provided herein, all notices, requests, consents, claims, demands, waivers and other communications hereunder
shall be in writing and shall be deemed to have been given: (i) when delivered by hand (with written confirmation of receipt);
(ii) when received by the addressee if sent by a nationally recognized overnight courier (receipt requested); (iii) on the date
sent by facsimile or e-mail of a PDF document (with confirmation of transmission) if sent during normal business hours of the recipient,
and on the next business day if sent after normal business hours of the recipient; or (iv) on the third day after the date mailed,
by certified or registered mail, return receipt requested, postage prepaid. Such communications must be sent (x) to the Corporation,
at its principal executive offices and (y) to any Holder, at such Holder’s address at it appears in the stock records of
the Corporation (or at such other address for a Holder as shall be specified in a notice given in accordance with this Section
10(c)).

 

(d)          Amendment
and Waiver. Notwithstanding any provision in the Certificate of Designation to the contrary, no provision contained in this
Certificate of Designation may be amended, modified or waived except by an instrument in writing executed by the Corporation all
of the Holders of the shares of Series D Convertible Preferred Stock then outstanding. Without limiting the generality of the foregoing,
no amendment, modification or waiver of the terms or relative priorities of the Series D Convertible Preferred Stock may be accomplished
by the merger, consolidation or other transaction of the Corporation with another corporation or entity unless the Corporation
has obtained the prior written consent of all of the Holders in accordance with this Section 10(d).

 

    	 	15	 

     

    

 

IN WITNESS WHEREOF,
the Corporation has caused this Certificate of Designation to be signed by the undersigned this ____ day of __________, 2016.

 

	 	GRANDPARENTS.COM, INC.

 

	 	By:	 
	 	 	Steve Leber
	 	 	President and CEO

 

    	 	16	 

     

    

 

EXHIBIT B

 

     

     

    

 

Indemnification
Agreement

 

This
Indemnification Agreement (this “Agreement”) is made and entered into this ___th day of __________________,
2015, by and between Grandparents.com, Inc., a Delaware corporation (the “Company”), and _______________
(“Indemnitee”).

 

Whereas,
qualified persons are reluctant to serve corporations as directors or otherwise unless they are provided with broad indemnification
and insurance against claims arising out of their service to and activities on behalf of the corporations; and

 

Whereas,
the Company has determined that attracting and retaining such persons is in the best interests of the Company’s stockholders
and that it is reasonable, prudent and necessary for the Company to indemnify such persons to the fullest extent permitted by applicable
law and to provide reasonable assurance regarding insurance;

 

Now,
therefore, the Company and Indemnitee hereby agree as follows:

 

1.          Defined
Terms; Construction.

 

(a)          Defined
Terms. As used in this Agreement, the following terms shall have the following meanings:

 

“Change in Control”
means, and shall be deemed to have occurred if, on or after the date of this Agreement, (i) any “person” (as
such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), other than (A) a trustee
or other fiduciary holding securities under an employee benefit plan of the Company or any of its subsidiaries acting in such capacity,
or (B) a corporation owned directly or indirectly by the stockholders of the Company in substantially the same proportions
as their ownership of stock of the Company, is or becomes the “beneficial owner” (as defined in Rule 13d-3 under said
Act), directly or indirectly, of securities of the Company representing more than 35% of the total voting power represented by
the Company’s then outstanding Voting Securities, (ii) during any period of two consecutive years, individuals who
at the beginning of such period constitute the board of directors of the Company and any new director whose election by the board
of directors of the Company or nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds
(2/3) of the directors then still in office who either were directors at the beginning of the period or whose election or nomination
for election was previously so approved, cease for any reason to constitute a majority thereof, (iii) the stockholders of
the Company approve a merger or consolidation of the Company with any other corporation other than a merger or consolidation that
would result in the Voting Securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining
outstanding or by being converted into Voting Securities of the surviving entity) at least 50% of the total voting power represented
by the Voting Securities of the Company or such surviving entity outstanding immediately after such merger or consolidation, (iv)
the stockholders of the Company approve a plan of complete liquidation of the Company or an agreement for the sale or disposition
by the Company of (in one transaction or a series of related transactions) all or substantially all of its assets, or (v)
the Company shall file or have filed against it, and such filing shall not be dismissed, any bankruptcy, insolvency or dissolution
proceedings, or a trustee, administrator or creditors committee shall be appointed to manage or supervise the affairs of the Company.

 

    	 	1	 

     

    

 

“Corporate Status”
means the status of a person who is or was a director (or a member of any committee of a board of directors), officer, employee
or agent (including without limitation a manager of a limited liability company) of the Company or any of its subsidiaries, or
of any predecessor thereof, or is or was serving at the request of the Company as a director (or a member of any committee of a
board of directors), officer, employee or agent (including without limitation a manager of a limited liability company) of another
entity, or of any predecessor thereof, including service with respect to an employee benefit plan.

 

“Determination”
means a determination that either (x) there is a reasonable basis for the conclusion that indemnification of Indemnitee
is proper in the circumstances because Indemnitee met a particular standard of conduct (a “Favorable Determination”)
or (y) there is no reasonable basis for the conclusion that indemnification of Indemnitee is proper in the circumstances
because Indemnitee met a particular standard of conduct (an “Adverse Determination”). An Adverse Determination
shall include the decision that a Determination was required in connection with indemnification and the decision as to the applicable
standard of conduct.

 

“DGCL” means the
General Corporation Law of the State of Delaware, as amended from time to time.

 

“Expenses” means
all (i) attorneys’ fees and expenses, retainers, court, arbitration and mediation costs, transcript costs, fees and expenses
of experts, witness and public relations consultants bonds and fees, traveling expenses, costs of collecting and producing documents,
travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees and all other
disbursements or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or
defend, investigating, being or preparing to be a witness in, appealing or otherwise participating in a Proceeding or responding
to, or objecting to, a request to provide discovery in any Proceeding, (ii) damages, judgments, fines and amounts paid in settlement
and any other amounts that Indemnitee becomes legally obligated to pay (including any federal, state or local taxes imposed on
Indemnitee as a result of receipt of reimbursements or advances of expenses under this Agreement) and (iii) the premium, security
for, and other costs relating to any costs bond, supersedes bond or other appeal bond or its equivalent, whether civil, criminal,
arbitrational, administrative or investigative with respect to any Proceeding actually and reasonably incurred by Indemnitee, or
on Indemnitee’s behalf, because of any claim or claims made against or by him in connection with any Proceeding, whether
formal or informal (including an action by or in the right of the Company), to which Indemnitee is, was or at any time becomes
a party or a witness, or is threatened to be made a party to, participant in or a witness with respect to, by reason of Indemnitee’
Corporate Status.

 

“Independent Legal Counsel”
means an attorney or firm of attorneys competent to render an opinion under the applicable law, selected in accordance with the
provisions of Section 5(e), who has not performed any services (other than services similar to those contemplated to be performed
by Independent Legal Counsel under this Agreement) for the Company or any of its subsidiaries or for Indemnitee within the last
three years.

 

    	 	2	 

     

    

 

“Proceeding” means
a threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, including
without limitation a claim, demand, discovery request, formal or informal investigation, inquiry, administrative hearing, arbitration
or other form of alternative dispute resolution, including an appeal from any of the foregoing.

 

“Voting Securities”
means any securities of the Company that vote generally in the election of directors.

 

(b)          Construction.
For purposes of this Agreement,

 

(i)          References
to the Company and any of its “subsidiaries” shall include any corporation, limited liability company, partnership,
joint venture, trust or other entity or enterprise that before or after the date of this Agreement is party to a merger or consolidation
with the Company or any such subsidiary or that is a successor to the Company as contemplated by Section 8(e) (whether or not such
successor has executed and delivered the written agreement contemplated by Section 8(e)).

 

(ii)         References
to “fines” shall include any excise taxes assessed on Indemnitee with respect to an employee benefit plan.

 

(iii)        References
to a “witness” in connection with a Proceeding shall include any interviewee or person called upon to produce documents
in connection with such Proceeding.

 

2.          Agreement
to Serve.

 

Indemnitee agrees to serve as a director
of the Company or one or more of its subsidiaries and in such other capacities as Indemnitee may serve at the request of the Company
from time to time, and by its execution of this Agreement the Company confirms its request that Indemnitee serve as a director
and in such other capacities. Indemnitee shall be entitled to resign or otherwise terminate such service with immediate effect
at any time, and neither such resignation or termination nor the length of such service shall affect Indemnitee’s rights
under this Agreement. This Agreement shall not constitute an employment agreement, supersede any employment agreement to which
Indemnitee is a party or create any right of Indemnitee to continued employment or appointment.

 

3.          Indemnification.

 

(a)          General
Indemnification. The Company shall indemnify Indemnitee, to the fullest extent permitted by applicable law in effect on the
date hereof or as amended to increase the scope of permitted indemnification, against Expenses, losses, liabilities, judgments,
fines, penalties and amounts paid in settlement (including all interest, taxes, assessments and other charges in connection therewith)
incurred by Indemnitee or on Indemnitee’s behalf in connection with any Proceeding in any way connected with, resulting from
or relating to Indemnitee’s Corporate Status.

 

    	 	3	 

     

    

 

(b)          Additional
Indemnification Regarding Expenses. Without limiting the foregoing, in the event any Proceeding is initiated by Indemnitee,
the Company or any other person to enforce or interpret this Agreement or any rights of Indemnitee to indemnification or advancement
of Expenses (or related obligations of Indemnitee) under the Company’s or any such subsidiary’s certificate of incorporation,
bylaws or other organizational agreement or instrument, any other agreement to which Indemnitee and the Company or any of its subsidiaries
are party, any vote of stockholders or directors of the Company or any of its subsidiaries, the DGCL, any other applicable law
or any liability insurance policy, the Company shall indemnify Indemnitee against Expenses incurred by Indemnitee or on Indemnitee’s
behalf in connection with such Proceeding in proportion to the success achieved by Indemnitee in such Proceeding and the efforts
required to obtain such success, as determined by the court presiding over such Proceeding.

 

(c)          Partial
Indemnification. If Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for a portion
of any Expenses, losses, liabilities, judgments, fines, penalties and amounts paid in settlement incurred by Indemnitee, but not
for the total amount thereof, the Company shall nevertheless indemnify Indemnitee for such portion.

 

(d)          Nonexclusivity.
The indemnification provided by this Agreement shall not be deemed exclusive of any rights to which Indemnitee may be entitled
under the certificate of incorporation, bylaws or other organizational agreement or instrument of the Company or any of its subsidiaries,
any other agreement, any vote of stockholders or directors, the DGCL, any other applicable law or any liability insurance policy.

 

(e)          Exceptions.
Any other provision herein to the contrary notwithstanding, the Company shall not be obligated under the Agreement to indemnify
Indemnitee:

 

(i)          For
Expenses incurred in connection with Proceedings initiated or brought voluntarily by the Indemnitee and not by way of defense,
counterclaim or crossclaim, except (x) as contemplated by Section 3(b), (y) in specific cases if the board of directors
of the Company has approved the initiation or bringing of such Proceeding, and (z) as may be required by law.

 

(ii)         For
an accounting of profits arising from the purchase and sale by the Indemnitee of securities within the meaning of Section 16(b)
of the Securities Exchange Act of 1934, as amended, or any similar provisions of any federal, state or local law if the final,
non-appealable judgment of a court of competent jurisdiction finds Indemnitee to be liable for disgorgement under such Section
16(b).

 

(iii)        On
account of Indemnitee’s conduct that is established by a final, non-appealable judgment of a court of competent jurisdiction
as knowingly fraudulent or deliberately dishonest or that constituted willful misconduct.

 

    	 	4	 

     

    

 

(iv)        For
which payment is actually made to Indemnitee under a valid and collectible insurance policy or under a valid and enforceable indemnity
clause, bylaw or agreement, except in respect of any excess beyond payment actually received by Indemnitee under such insurance,
clause, bylaw or agreement.

 

(v)         if
and to the extent indemnification is prohibited by applicable law.

 

(f)          Subrogation.
In the event of payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights
of recovery of the Indemnitee, who shall execute such documents and do such acts as the Company may reasonably request to secure
such rights and to enable the Company effectively to bring suit to enforce such rights.

 

4.          Advancement
of Expenses.

 

The Company shall pay all Expenses incurred
by Indemnitee in connection with any Proceeding in any way connected with, resulting from or relating to Indemnitee’s Corporate
Status, other than a Proceeding initiated by Indemnitee for which the Company would not be obligated to indemnify Indemnitee pursuant
to Section 3(e)(i), in advance of the final disposition (in accordance with Section 5(c)) of such Proceeding and without regard
to whether Indemnitee will ultimately be entitled to be indemnified for such Expenses and without regard to whether an Adverse
Determination has been made, except as contemplated by the last sentence of Section 5(f). The right to advances under this Section
4 shall in all events continue until final disposition of any Proceeding, including any appeal therein. Advances shall be made
without regard to Indemnitee’s ability to repay the expenses and without regard to Indemnitee’s ultimate entitlement
to indemnification under the other provisions of this Agreement. Indemnitee shall qualify for advances upon the execution and delivery
to the Company of this Agreement, and Indemnitee shall repay such amounts advanced only if and to the extent that it shall ultimately
be determined in a decision by a court of competent jurisdiction from which no appeal can be taken that Indemnitee is not entitled
to be indemnified by the Company for such Expenses. The right to advancement described in this Section 4 is vested. Such repayment
obligation shall be unsecured and shall not bear interest. The Company shall not impose on Indemnitee additional conditions to
advancement or require from Indemnitee additional undertakings regarding repayment.

 

5.          Indemnification
Procedure.

 

(a)          Notice
of Proceeding; Cooperation. Indemnitee shall give the Company notice in writing as soon as practicable, and in any event, no
later than 30 days after Indemnitee becomes aware, of any Proceeding for which indemnification will or could be sought under this
Agreement, provided that any failure or delay in giving such notice shall not relieve the Company of its obligations under
this Agreement unless and to the extent that (i) none of the Company and its subsidiaries are party to or aware of such Proceeding
and (ii) the Company is materially prejudiced by such failure.

 

    	 	5	 

     

    

 

(b)          Settlement.
The Company will not, without the prior written consent of Indemnitee, which may be provided or withheld in Indemnitee’s
sole discretion, effect any settlement of any Proceeding against Indemnitee or which could have been brought against Indemnitee
unless such settlement solely involves the payment of money by persons other than Indemnitee and includes an unconditional release
of Indemnitee from all liability on any matters that are the subject of such Proceeding and an acknowledgment that Indemnitee denies
all wrongdoing in connection with such matters. The Company shall not be obligated to indemnify Indemnitee against amounts paid
in settlement of a Proceeding against Indemnitee if such settlement is effected by Indemnitee without the Company’s prior
written consent, which shall not be unreasonably withheld.

 

(c)          Request
for Payment; Timing of Payment. To obtain indemnification payments or advances under this Agreement, Indemnitee shall submit
to a Company a written request therefor, together with such invoices or other supporting information as may be reasonably requested
by the Company and reasonably available to Indemnitee. The Company shall make indemnification payments to Indemnitee no later than
30 days, and advances to Indemnitee no later than 20 days, after receipt of the written request of Indemnitee.

 

(d)          Determination.
The Company intends that Indemnitee shall be indemnified to the fullest extent permitted by law as provided in Section 3 and that
no Determination shall be required in connection with such indemnification. In no event shall a Determination be required in connection
with advancement of Expenses pursuant to Section 4 or in connection with indemnification for Expenses incurred as a witness or
incurred in connection with any Proceeding or portion thereof with respect to which Indemnitee has been successful on the merits
or otherwise. Any decision that a Determination is required by law in connection with any other indemnification of Indemnitee,
and any such Determination, shall be made within 30 days after receipt of Indemnitee’s written request for indemnification,
as follows:

 

(i)          If
no Change in Control has occurred, (w) by a majority vote of the directors of the Company who are not parties to such Proceeding,
even though less than a quorum, with the advice of Independent Legal Counsel, or (x) by a committee of such directors designated
by majority vote of such directors, even though less than a quorum, with the advice of Independent Legal Counsel, or (y)
if there are no such directors, or if such directors so direct, by Independent Legal Counsel in a written opinion to the Company
and Indemnitee, or (z) by the stockholders of the Company.

 

(ii)         If
a Change in Control has occurred, by Independent Legal Counsel in a written opinion to the Company and Indemnitee.

 

The Company shall pay all Expenses incurred by Indemnitee in
connection with a Determination.

 

(e)          Independent
Legal Counsel. If there has not been a Change in Control, Independent Legal Counsel shall be selected by the board of directors
of the Company and approved by Indemnitee (which approval shall not be unreasonably withheld or delayed). If there has been a Change
in Control, Independent Legal Counsel shall be selected by Indemnitee and approved by the Company (which approval shall not be
unreasonably withheld or delayed). The Company shall pay the fees and expenses of Independent Legal Counsel and indemnify Independent
Legal Counsel against any and all expenses (including attorneys’ fees), claims, liabilities and damages arising out of or
relating to its engagement.

 

    	 	6	 

     

    

 

(f)          Consequences
of Determination; Remedies of Indemnitee. The Company shall be bound by and shall have no right to challenge a Favorable Determination.
If an Adverse Determination is made, or if for any other reason the Company does not make timely indemnification payments or advances
of Expenses, Indemnitee shall have the right to commence a Proceeding before a court of competent jurisdiction to challenge such
Adverse Determination and/or to require the Company to make such payments or advances. Indemnitee shall be entitled to be indemnified
for all Expenses incurred in connection with such a Proceeding in accordance with Section 3(b) and to have such Expenses advanced
by the Company in accordance with Section 4. If Indemnitee fails to timely challenge an Adverse Determination, or if Indemnitee
challenges an Adverse Determination and such Adverse Determination has been upheld by a final judgment of a court of competent
jurisdiction from which no appeal can be taken, then, to the extent and only to the extent required by such Adverse Determination
or final judgment, the Company shall not be obligated to indemnify or advance Expenses to Indemnitee under this Agreement.

 

(g)          Presumptions;
Burden and Standard of Proof. In connection with any Determination, or any review of any Determination, by any person, including
a court:

 

(i)          It
shall be a presumption that a Determination is not required.

 

(ii)         It
shall be a presumption that Indemnitee has met the applicable standard of conduct and that indemnification of Indemnitee is proper
in the circumstances.

 

(iii)        The
burden of proof shall be on the Company to overcome the presumptions set forth in the preceding clauses (i) and (ii), and each
such presumption shall only be overcome if the Company establishes otherwise.

 

(iv)        The
termination of any Proceeding by judgment, order, finding, settlement (whether with or without court approval) or conviction, or
upon a plea of nolo contendere, or its equivalent, shall not create a presumption that indemnification is not proper or
that Indemnitee did not meet the applicable standard of conduct or that a court has determined that indemnification is not permitted
by this Agreement or otherwise.

 

(v)         Neither
the failure of any person or persons to have made a Determination nor an Adverse Determination by any person or persons shall be
a defense to Indemnitee’s claim or create a presumption that Indemnitee did not meet the applicable standard of conduct,
and any Proceeding commenced by Indemnitee pursuant to Section 5(1) shall be de novo with respect to all determinations
of fact and law.

 

    	 	7	 

     

    

 

6.          Directors
and Officers Liability Insurance.

 

(a)          Maintenance
of Insurance. So long as the Company or any of its subsidiaries maintains liability insurance for any directors, officers,
employees or agents of any such person, the Company shall ensure that Indemnitee is covered by such insurance in such a manner
as to provide Indemnitee the same rights and benefits as are accorded to the most favorably insured of the Company’s and
its subsidiaries’ then current directors and officers. If at any date (i) such insurance ceases to cover acts and omissions
occurring during all or any part of the period of Indemnitee’s Corporate Status or (ii) neither the Company nor any of its
subsidiaries maintains any such insurance, the Company shall ensure that Indemnitee is covered, with respect to acts and omissions
prior to such date, for at least six years (or such shorter period as is available on commercially reasonable terms) from such
date, by other directors and officers liability insurance, in amounts and on terms (including the portion of the period of Indemnitee’s
Corporate Status covered) no less favorable to Indemnitee than the amounts and terms of the liability insurance maintained by the
Company on the date hereof.

 

(b)          Notice
to Insurers. Upon receipt of notice of a Proceeding pursuant to Section 5(a), the Company shall give or cause to be given prompt
notice of such Proceeding to all insurers providing liability insurance in accordance with the procedures set forth in all applicable
or potentially applicable policies. The Company shall thereafter take all necessary action to cause such insurers to pay all amounts
payable in accordance with the terms of such policies.

 

7.          Limitation
of Liability. Indemnitee shall not be personally liable to the Company or any of its subsidiaries or to the stockholders of
the Company or any such subsidiary for monetary damages for breach of fiduciary duty as a director of the Company or any such subsidiary;
provided, however, that the foregoing shall not eliminate or limit the liability of the Indemnitee (i) for
any breach of the Indemnitee’s duty of loyalty to the Company or such subsidiary or the stockholders thereof; (ii)
for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of the law; (iii)
under Section 174 of the DGCL or any similar provision of other applicable corporations law; or (iv) for any transaction
from which the Indemnitee derived an improper personal benefit. If the DGCL or such other applicable law shall be amended to permit
further elimination or limitation of the personal liability of directors, then the liability of the Indemnitee shall, automatically,
without any further action, be eliminated or limited to the fullest extent permitted by the DGCL or such other applicable law as
so amended.

 

8.          Miscellaneous.

 

(a)          Non-Circumvention.
The Company shall not seek or agree to any order of any court or other governmental authority that would prohibit or otherwise
interfere, and shall not take or fail to take any other action if such action or failure would reasonably be expected to have the
effect of prohibiting or otherwise interfering, with the performance of the Company’s indemnification, advancement or other
obligations under this Agreement.

 

    	 	8	 

     

    

 

(b)          Severability.
If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable. for any reason whatsoever:
(i) the validity, legality and enforceability of the remaining provisions of this Agreement (including without limitation,
each portion of any section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that
is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable
to the fullest extent permitted by law; (ii) such provision or provisions shall be deemed reformed to the extent necessary
to conform to applicable law and to give the maximum effect to the intent of the parties hereto; and (iii) to the fullest
extent possible, the provisions of this Agreement (including, without limitation, each portion of any section of this Agreement
containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable)
shall be construed so as to give effect to the intent manifested thereby.

 

(c)          Notices.
All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed duly given
(i) on the date of delivery if delivered personally, or by facsimile, upon confirmation of receipt, (ii) on the first
business day following the date of dispatch if delivered by a recognized next-day courier service or (iii) on the third
business day following the date of mailing if delivered by domestic registered or certified mail, properly addressed, or on the
fifth business day following the date of mailing if sent by airmail from a country outside of North America, to Indemnitee at the
address shown on the signature page of this Agreement, to the Company at the address shown on the signature page of this Agreement,
or in either case as subsequently modified by written notice.

 

(d)          Amendment
and Termination. No amendment, modification, termination or cancellation of this Agreement shall be effective unless it is
in writing signed by all the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute
a waiver of any other provisions hereof (whether or not similar), nor shall such waiver constitute a continuing waiver.

 

(e)          Successors
and Assigns. This Agreement shall be binding upon the Company and its respective successors and assigns, including without
limitation any acquiror of all or substantially all of the Company’s assets or business, any person (as such term is used
in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) that acquires beneficial ownership of securities
of the Company representing more than 35% of the total voting power represented by the Company’s then outstanding Voting
Securities, and any survivor of any merger or consolidation to which the Company is party. The Company shall require and cause
any such successor, by written agreement in form and substance satisfactory to Indemnitee, expressly to assume and agree to perform
this Agreement as if it were named as the Company herein, and the Company shall not permit any such purchase of assets or business,
acquisition of securities or merger or consolidation to occur until such written agreement has been executed and delivered. No
such assumption and agreement shall relieve the Company of any of its obligations hereunder, and this Agreement shall not otherwise
be assignable by the Company. This Agreement is personal in nature and neither of the parties hereto shall, without the consent
of the other, assign or delegate this Agreement or any rights or obligations. Without limiting the generality or effect of the
foregoing, Indemnitee’s right to receive payments hereunder shall not be assignable, whether by pledge, creation of a security
interest or otherwise, other than by a transfer by the Indemnitee’s will or by estate law, and, in the event of any attempted
assignment or transfer contrary to this Section 8(e), the Company shall have no liability to pay any amount so attempted to be
assigned or transferred.

 

    	 	9	 

     

    

 

(f)          Choice
of Law; Consent to Jurisdiction. This Agreement shall be governed by and its provisions construed in accordance with the laws
of the State of Delaware, as applied to contracts between Delaware residents entered into and to be performed entirely within Delaware,
without regard to the conflict of law principles thereof. The Company and Indemnitee each hereby irrevocably consents to the jurisdiction
of the courts of the State of Delaware for all purposes in connection with any Proceeding which arises out of or relates to this
Agreement and agree that any action instituted under this Agreement shall be brought only in the state courts of the State of Delaware.

 

(g)          Integration
and Entire Agreement. This Agreement sets forth the entire understanding between the parties hereto and supersedes and merges
all previous written and oral negotiations, commitments, understandings and agreements relating to the subject matter hereof between
the parties hereto, provided that the provisions hereof shall not supersede the provisions of the Company’s certificate of
incorporation, bylaws or other organizational agreement or instrument, any other agreement, any vote of stockholders or directors,
the DGCL or other applicable law, to the extent any such provisions shall be more favorable to Indemnitee than the provisions hereof.

 

(h)          Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall constitute an original.

 

[Remainder of this page intentionally
left blank]

 

    	 	10	 

     

    

 

In
Witness Whereof, the parties hereto have executed this Agreement as of the date first above written.

 

	 	Grandparents.com, Inc.

 

	 	By:	 
	 	Name:
	 	Title:

 

Agreed to and Accepted:

 

Indemnitee:

 

	By:	 	 
	Name:	 
	Title:	 

 

	Address:	 	 
	 	 	 
	 	 	 

 

    	 	11Exhibit 10.4

 

Execution Version

 

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

 

This Amended and Restated
Registration Rights Agreement (the “Agreement”) is made and entered into as of this 15th day of September,
2016 by and between Grandparents.com, a Delaware corporation (the “Company”), and VB Funding, LLC, a Delaware
limited liability company (together with its participants, successors and assigns, “VB Funding”).

 

A.           VB
Funding and the Company previously entered into that certain Registration Rights Agreement dated as of July 8, 2015 by and between
Borrower and VB Funding (the “Original Agreement”).

 

B.           The
parties desire to amend and restate the Original Agreement in accordance with the terms and conditions set forth herein.

 

Capitalized terms used
herein have the respective meanings ascribed thereto in that certain Amended and Restated Credit Agreement, dated the date hereof,
by and between the Company and VB Funding, unless otherwise defined herein.

 

The parties hereby agree
as follows:

 

1.           Certain
Definitions.

 

As used in this Agreement,
the following terms shall have the following meanings:

 

“Investor”
means VB Funding and any Affiliate or permitted transferee of VB Funding who is a subsequent holder of any Note or Registrable
Securities.

 

“Prospectus”
means (i) the prospectus included in any Registration Statement, as amended or supplemented by any prospectus supplement, with
respect to the terms of the offering of any portion of the Registrable Securities covered by such Registration Statement and by
all other amendments and supplements to the prospectus, including post-effective amendments and all material incorporated by reference
in such prospectus, and (ii) any “free writing prospectus” as defined in Rule 405 under the 1933 Act.

 

“Register,”
“registered” and “registration” refer to a registration made by preparing and
filing a Registration Statement or similar document in compliance with the 1933 Act (as defined below), and the declaration or
ordering of effectiveness of such Registration Statement or document.

 

“Registrable
Securities” the (i) the shares of Common Stock issuable upon conversion of any Note, including any interest paid
as a result of an increase in the principal amount of any Note pursuant to the terms thereof, (ii) the shares of Common Stock issuable
pursuant to the Common Stock SPA, (iii) the shares of Common Stock issuable upon conversion of the Series D Preferred Stock issuable
pursuant to the Preferred Stock SPA, and (iii) any other securities issued or issuable with respect to or in exchange for Registrable
Securities, whether by way of stock dividend, stock-split, or in connection with or combination of shares, recapitalization, merger,
charter amendment or otherwise; provided, that, a security shall cease to be a Registrable Security upon (A) sale pursuant to a
Registration Statement or Rule 144 under the 1933 Act, or (B) such security becoming eligible for sale without restriction by VB
Funding pursuant to Rule 144.

 

    	 	1	 

     

    

 

“Registration
Statement” means any registration statement of the Company filed under the 1933 Act that covers the resale of any
of the Registrable Securities pursuant to the provisions of this Agreement, amendments and supplements to such Registration Statement,
including post-effective amendments, all exhibits and all material incorporated by reference in such Registration Statement.

 

“Required Investors”
means the Investors holding a majority of the Registrable Securities as of a Trigger Date.

 

“SEC”
means the U.S. Securities and Exchange Commission.

 

“1933 Act”
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“1934 Act”
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

2.           Registration.

 

(a)          Registration
Statements.

 

(i)          The
Company hereby agrees to prepare and file with the SEC one Registration Statement on Form S-1 covering the resale of the Registrable
Securities (the “Resale Registration Statement”) on a date which is no later than sixty (60) days after the
date of the occurrence of the earlier of any of the following (the “Filing Deadline”): (x) VB Funding’s
notice of conversion of the Series D Preferred Stock, and (y) VB Funding becoming the beneficial owner (as defined in Section 13(d)
of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder) of 10% or more of the
Company’s issued and outstanding shares of Common Stock (each, a “Trigger Date”). Such Resale Registration
Statement also shall cover, to the extent allowable under the 1933 Act and the rules promulgated thereunder (including Rule 416),
such indeterminate number of additional shares of Common Stock resulting from stock splits, stock dividends or similar transactions
with respect to the Conversion Registrable Securities.

 

(ii)         Except
for shares of Common Stock (x) issuable upon conversion of the Company’s Redeemable Convertible 7.5% Preferred Stock, par
value $0.01, if issued (the “Series C Preferred Stock”), and (y) shares of Common Stock outstanding or
issuable upon exercise of warrants that are entitled to piggyback registration rights as of the date of this Agreement (the “Piggyback
Securities”), the Company shall not include in the Resale Registration Statement any shares of Common Stock or other
securities for the account of any other holder without the prior written consent of VB Funding, in its sole discretion. The Registration
Statement (and each amendment or supplement thereto, and each request for acceleration of effectiveness thereof) shall be provided
in accordance with Section 3(c) to VB Funding and its counsel prior to its filing or other submission.

 

    	 	2	 

     

    

 

(iii)        It
is anticipated that any Registration Statement filed pursuant to this Agreement with the SEC may allow for different means of distribution,
including sales by means of an underwriting as well as sales into the open market. Subject to any SEC comments, such Registration
Statement shall include the plan of distribution attached hereto as Exhibit A; provided, however, that no Investors shall
be named as an “underwriter” in the Registration Statement without Investor’s prior written consent. If VB Funding
or the Required Investors desire to distribute all or part of the Registrable Securities by means of an underwriting, they shall
so advise the Company in writing as soon as practicable after such a determination has been made, and such underwriter shall be
a reputable, unrelated third party bank, which shall be subject to the approval of the Company’s Board of Directors, which
approval shall not be unreasonably withheld, conditioned or delayed. A determination of whether all or part of the distribution
will be by means of an underwriting shall be made by VB Funding or the Required Investors making the request. If all or part of
the distribution is to be by means of an underwriting, all subsequent decisions concerning the underwriting which are to be made
by VB Funding or the Required Investors pursuant to this Agreement (which shall include selection of the underwriter or underwriters
to be engaged) shall be subject to the reasonable approval of the Company’s Board of Directors, which approval shall not
be unreasonably withheld, conditioned or delayed.

 

(iv)        If
a Registration Statement filed pursuant to this Agreement involves an underwritten offering and the managing underwriter or underwriters
shall advise the Company in writing that, in their opinion, the total number of Registrable Securities and, as permitted hereunder,
other securities requested to be included in such offering (including shares of Common Stock issuable upon conversion of the Series
C Preferred Stock) exceeds the number which can be sold in such offering without an adverse effect on the success of such offering,
then the Company will include in such Registration Statement, to the extent of the number which the Company is so advised can be
sold in such offering without having such an adverse effect: (x) first, prior to the inclusion of any securities which are not
Registrable Securities, all of the Registrable Securities hereof or, if all such Registrable Securities cannot be included in such
underwritten offering, all of the Registrable Securities that can to the extent of the number which the Company is so advised can
be sold in such offering, and (y) second, the shares of Common Stock issuable upon conversion of the Series C Preferred Stock,
allocated on a pro rata basis among the holders thereof based upon the total number of shares of such other securities proposed
to be included in the registration, and (z) all other securities which are permitted to be included in such Registration Statement
pursuant to Section 2(a)(ii) of this Agreement, allocated on a pro rata basis among the holders thereof based upon the total number
of shares of such other securities proposed to be included in the registration. All holders proposing to distribute their shares
through an underwriting shall enter into an underwriting agreement in customary form with the underwriter or underwriters selected
for such underwriting.

 

(v)         In
any registered offering pursuant to this Agreement that becomes effective under the 1933 Act, the Company shall use its commercially
reasonable best efforts to keep available to the holder of such Registrable Securities a Prospectus meeting the requirements of
Section 10(a)(3) of the 1933 Act and shall file all amendments and supplements under the 1933 Act required for those purposes during
the Effectiveness Period (defined below). The Company agrees to supplement or amend such Registration Statement, if required by
the rules and regulations or instructions applicable to the registration form utilized by the Company, or, if applicable, the rules
and regulations thereunder for shelf registrations pursuant to Rule 415 promulgated under the 1933 Act, or as reasonably requested
by holders of Registrable Securities covered by the Registration Statement, or any underwriter of the Registrable Securities. In
any offering pursuant to this Agreement, the Company will promptly use its commercially reasonable best efforts to effect such
qualification and compliance as may be requested and as would permit or facilitate the distribution of the Registrable Securities,
including, without limitation, appropriate qualifications under applicable blue sky or other state securities laws, appropriate
compliance with any other governmental requirements and listing on a national securities exchange or inter-dealer quotation system
on which the Registrable Securities are then listed.

 

    	 	3	 

     

    

 

(b)          Expenses.
The Company will pay all expenses associated with performance of or compliance with this Agreement, including all registration,
qualification and filing fees and expenses, printing fees, the Company’s counsel and accounting fees and expenses, costs
associated with clearing the Registrable Securities for sale under applicable state securities laws, listing fees, fees and expenses
of one counsel to VB Funding and VB Funding’s reasonable expenses in connection with the registration, but excluding discounts,
commissions, fees of underwriters, selling brokers, dealer managers or similar securities industry professionals with respect to
the Registrable Securities being sold.

 

(c)          Effectiveness.

 

(i)          The
Company shall use commercially reasonable best efforts to cause the Registration Statements declared effective by the SEC as soon
as practicable, but in no event later than the earlier of: (i) if the SEC shall have informed the Company that no review of the
Registration Statement will be made or that the SEC has no further comments on the Registration Statement, five (5) Business Days
after such notice from the SEC, or (ii) the 120th day if the SEC reviews the Registration Statement. The Company shall
notify VB Funding by facsimile or e-mail as promptly as practicable, and in any event, within twenty-four (24) hours, after any
Registration Statement is declared effective, and shall simultaneously provide Investors with copies of any related Prospectus
to be used in connection with the sale or other disposition of the securities covered thereby.

 

(ii)         For
not more than twenty (20) consecutive days or for a total of not more than forty-five (45) days in any twelve (12) month period,
the Company may suspend the use of any Prospectus included in any Registration Statement contemplated by this Section in the event
that the Company determines in good faith that such suspension is necessary to (A) delay the disclosure of material non-public
information concerning the Company, the disclosure of which at the time is not, in the good faith opinion of the Company, in the
best interests of the Company or (B) amend or supplement the affected Registration Statement or the related Prospectus so that
such Registration Statement or Prospectus shall not include an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein, in the case of the Prospectus in light of the circumstances
under which they were made, not misleading (an “Allowed Delay”); provided, that the Company shall promptly (a)
notify each Investor in writing of the commencement of an Allowed Delay, but shall not (without the prior written consent of an
Investor) disclose to an Investor any material non-public information giving rise to an Allowed Delay, (b) advise the Investors
in writing to cease all sales under the Registration Statement until the end of the Allowed Delay and (c) use commercially reasonable
best efforts to terminate an Allowed Delay as promptly as practicable.

 

    	 	4	 

     

    

 

(d)          Rule
415; Cutback If at any time the SEC takes the position that the offering of some or all of the Registrable Securities in a
Registration Statement is not eligible to be made on a delayed or continuous basis under the provisions of Rule 415 under the 1933
Act or requires any Investor to be named as an “underwriter,” the Company shall use its commercially reasonable best
efforts to persuade the SEC that the offering contemplated by the Registration Statement is a valid secondary offering and not
an offering “by or on behalf of the issuer” as defined in Rule 415 and that none of the Investors is an “underwriter.”
VB Funding shall have the right to participate or have its counsel participate in any meetings or discussions with the SEC regarding
the SEC’s position and to comment or have its counsel comment on any written submission made to the SEC with respect thereto.
No such written submission shall be made to the SEC to which VB Funding’s counsel reasonably objects. In the event that,
despite the Company’s efforts and compliance with the terms of this Section 2(d), the SEC refuses to alter its position,
the Company shall (i) remove from the Registration Statement such portion of the Registrable Securities (the “Cut Back
Shares”) and/or (ii) agree to such restrictions and limitations on the registration and resale of the Registrable Securities
as the SEC may require to assure the Company’s compliance with the requirements of Rule 415 (collectively, the “SEC
Restrictions”); provided, however, that the Company shall not agree to name any Investor as an “underwriter”
in such Registration Statement without the prior written consent of such Investor. Any cut-back imposed on the Investors pursuant
to this Section 2(d) shall be allocated to among the Investors on a pro rata basis. From and after such date as the Company is
able to effect the registration of such Cut Back Shares in accordance with any SEC Restrictions (such date, the “Restriction
Termination Date” of such Cut Back Shares), all of the provisions of this Section 2 shall again be applicable to such
Cut Back Shares; provided, however, that (i) the Filing Deadline for the Registration Statement including such Cut Back Shares
(“Cutback Registration Statement”) shall be ten (10) Business Days after such Restriction Termination Date,
and (ii) the date by which the Company is required to obtain effectiveness with respect to such Cut Back Shares under Section 2(c)
shall be the 90th day immediately after the Restriction Termination Date (the 120th day if the SEC reviews
the Registration Statement).

 

3.           Company
Obligations. The Company will use commercially reasonable best efforts to effect the registration of the Registrable Securities
in accordance with the terms hereof, and pursuant thereto the Company will, as expeditiously as possible:

 

(a)          use
commercially reasonable best efforts to cause the Resale Registration Statement or the Cutback Registration statement, as the case
may be, to become effective and to remain continuously effective for a period that will terminate upon the earlier of (i) the date
on which all Registrable Securities covered by such Registration Statement as amended from time to time, have been sold, and (ii)
the date on which all Registrable Securities may be sold without restriction pursuant to Rule 144 (the “Effectiveness
Period”) and advise the Investors in writing when the Effectiveness Period has expired;

 

(b)          prepare
and file with the SEC such amendments and post-effective amendments to the Registration Statement and the Prospectus as may be
necessary to keep the Registration Statement effective for the Effectiveness Period and to comply with the provisions of the 1933
Act and the 1934 Act with respect to the distribution of all of the Registrable Securities covered thereby;

 

(c)          provide
copies to and permit counsel designated by VB Funding to review each Registration Statement and all amendments and supplements
thereto no fewer than seven (7) days prior to its filing with the SEC and not file any document to which such counsel reasonably
objects;

 

    	 	5	 

     

    

 

(d)          furnish
to VB Funding and its legal counsel (i) promptly after the same is prepared and publicly distributed, filed with the SEC, or received
by the Company (but not later than two (2) Business Days after the filing date, receipt date or sending date, as the case may be)
one (1) copy of any Registration Statement and any amendment thereto, each preliminary prospectus and Prospectus and each amendment
or supplement thereto, and each letter written by or on behalf of the Company to the SEC or the staff of the SEC, and each item
of correspondence from the SEC or the staff of the SEC, in each case relating to such Registration Statement (other than any portion
of any thereof which contains information for which the Company has sought confidential treatment), and (ii) such number of copies
of a Prospectus, including a preliminary prospectus, and all amendments and supplements thereto and such other documents as each
Investor may reasonably request in order to facilitate the disposition of the Registrable Securities owned by such Investor that
are covered by the related Registration Statement;

 

(e)          use
commercially reasonable efforts to (i) prevent the issuance of any stop order or other suspension of effectiveness and, (ii) if
such order is issued, obtain the withdrawal of any such order at the earliest possible moment;

 

(f)           prior
to any public offering of Registrable Securities, use commercially reasonable best efforts to register or qualify or cooperate
with VB Funding and its counsel in connection with the registration or qualification of such Registrable Securities for offer and
sale under the securities or blue sky laws of such jurisdictions requested by VB Funding and do any and all other commercially
reasonable acts or things necessary or advisable to enable the distribution in such jurisdictions of the Registrable Securities
covered by the Registration Statement; provided, however, that the Company shall not be required
in connection therewith or as a condition thereto to (i) qualify to do business in any jurisdiction where it would not otherwise
be required to qualify but for this Section 3(f), (ii) subject itself to general taxation in any jurisdiction where it would not
otherwise be so subject but for this Section 3(f), or (iii) file a general consent to service of process in any such jurisdiction;

 

(g)          use
commercially reasonable best efforts to cause all Registrable Securities covered by a Registration Statement to be listed on each
securities exchange, interdealer quotation system or other market on which similar securities issued by the Company are then listed;

 

(h)          immediately
notify the Investors, at any time prior to the end of the Effectiveness Period, upon discovery that, or upon the happening of any
event as a result of which, the Prospectus includes an untrue statement of a material fact or omits to state any material fact
required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing,
and promptly prepare, file with the SEC and furnish to such holder a supplement to or an amendment of such Prospectus as may be
necessary so that such Prospectus shall not include an untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing;

 

    	 	6	 

     

    

 

(i)           otherwise
use commercially reasonable best efforts to comply with all applicable rules and regulations of the SEC under the 1933 Act and
the 1934 Act, including, without limitation, Rule 172 under the 1933 Act, file any final Prospectus, including any supplement or
amendment thereof, with the SEC pursuant to Rule 424 under the 1933 Act, promptly inform the Investors VB Funding in writing if,
at any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result
thereof, the Investors are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take
such other actions as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder; and make
available to its security holders, as soon as reasonably practicable, but not later than the Availability Date (as defined below),
an earnings statement covering a period of at least twelve (12) months, beginning after the effective date of each Registration
Statement, which earnings statement shall satisfy the provisions of Section 11(a) of the 1933 Act, including Rule 158 promulgated
thereunder (for the purpose of this subsection 3(i), “Availability Date” means the 45th day following the end of the
fourth fiscal quarter that includes the effective date of such Registration Statement, except that, if such fourth fiscal quarter
is the last quarter of the Company’s fiscal year, “Availability Date” means the 90th day after the end
of such fourth fiscal quarter); and

 

(j)           With
a view to making available to the Investors the benefits of Rule 144 (or its successor rule) and any other rule or regulation of
the SEC that may at any time permit the Investors to sell shares of Common Stock to the public without registration, the Company
covenants and agrees to: (i) make and keep public information available, as those terms are understood and defined in Rule 144,
until the earlier of (A) six months after such date as all of the Registrable Securities may be sold without restriction by the
holders thereof pursuant to Rule 144 or any other rule of similar effect or (B) such date as all of the Registrable Securities
shall have been resold; (ii) file with the SEC in a timely manner all reports and other documents required of the Company under
the 1934 Act; and (iii) furnish to each Investor upon request, as long as such Investors owns any Registrable Securities, (A) a
written statement by the Company that it has complied with the reporting requirements of the 1934 Act, (B) a copy of the Company’s
most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q, and (C) such other information as may be reasonably requested
in order to avail VB Funding of any rule or regulation of the SEC that permits the selling of any such Registrable Securities without
registration.

 

4.           Due
Diligence Review; Information. The Company shall make available, during normal business hours, for inspection and review by
the Investors, advisors to and representatives of the Investors (who may or may not be affiliated with VB Funding and who are reasonably
acceptable to the Company), all financial and other records, all SEC Filings (as defined in the Credit Agreement) and other filings
with the SEC, and all other corporate documents and properties of the Company as may be reasonably necessary for the purpose of
such review, and cause the Company’s officers, directors and employees, within a reasonable time period, to supply all such
information reasonably requested by the Investors or any such representative, advisor or underwriter in connection with such Registration
Statement (including, without limitation, in response to all questions and other inquiries reasonably made or submitted by any
of them), prior to and from time to time after the filing and effectiveness of the Registration Statement for the sole purpose
of enabling the Investors and such representatives, advisors and underwriters and their respective accountants and attorneys to
conduct initial and ongoing due diligence with respect to the Company and the accuracy of such Registration Statement.

 

    	 	7	 

     

    

 

The Company shall not disclose
material nonpublic information to the Investors, or to advisors to or representatives of the Investors, unless prior to disclosure
of such information the Company identifies such information as being material nonpublic information and provides the Investors,
such advisors and representatives with the opportunity to accept or refuse to accept such material nonpublic information for review
and if any Investor wishing to obtain such information enters into an appropriate confidentiality agreement with the Company with
respect thereto.

 

5.           Obligations
of the Investors.

 

(a)          Each
Investor shall furnish in writing to the Company such information regarding itself, the Registrable Securities held by it and the
intended method of disposition of the Registrable Securities held by it, as shall be reasonably required to effect the registration
of such Registrable Securities and shall execute such documents in connection with such registration as the Company may reasonably
request. At least five (5) Business Days prior to the first anticipated filing date of any Registration Statement, the Company
shall notify each Investor of the information the Company requires from such Investor if such Investor elects to have any of the
Registrable Securities included in the Registration Statement. Such Investor shall provide such information to the Company at least
two (2) Business Days prior to the first anticipated filing date of such Registration Statement if such Investor elects to have
any of the Registrable Securities included in the Registration Statement.

 

(b)          Each
Investor, by its acceptance of the Registrable Securities for registration in a Registration Statement to be filed with the SEC
hereunder shall be required to agree to cooperate with the Company as reasonably requested by the Company in connection with the
preparation and filing of such Registration Statement.

 

(c)          Each
Investor shall be required to agree that, upon receipt of any notice from the Company of either (i) the commencement of an Allowed
Delay pursuant to Section 2(c)(ii) or (ii) the happening of an event pursuant to Section 3(h) hereof, the Investor will immediately
discontinue disposition of Registrable Securities pursuant to the Registration Statement covering such Registrable Securities,
until such Investor is advised by the Company that such dispositions may again be made.

 

    	 	8	 

     

    

 

6.           Indemnification.

 

(a)          Indemnification
by the Company. The Company will indemnify and hold harmless VB Funding and each Investor and its officers, directors, members,
employees and agents, successors and assigns, and each other person, if any, who controls VB Funding or any such Investor within
the meaning of Section 15 of the 1933 Act, and the rules and regulations promulgated thereunder,
against any losses, claims, damages, liabilities, and expenses (including reasonable attorney fees), joint or several, to which
they may become subject under the 1933 Act or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions
or investigations in respect thereof) arise out of or are based upon: (i) any untrue statement or alleged untrue statement or omission
or alleged omission of any material fact contained in any Registration Statement, any preliminary Prospectus or final Prospectus,
or any amendment or supplement thereof; (ii) any blue sky application or other document executed by the Company specifically for
that purpose or based upon written information furnished by the Company filed in any state or other jurisdiction in order to qualify
any or all of the Registrable Securities under the securities laws thereof (any such application, document or information herein
called a “Blue Sky Application”); (iii) the omission or alleged omission to state in a Blue Sky Application
a material fact required to be stated therein or necessary to make the statements therein not misleading; (iv) any violation by
the Company or its agents of any rule or regulation promulgated under the 1933 Act applicable to the Company or its agents and
relating to action or inaction required of the Company in connection with such registration; or (v) any failure to register or
qualify the Registrable Securities included in any such Registration Statement in any state where the Company or its agents has
affirmatively undertaken or agreed in writing that the Company will undertake such registration or qualification on an Investor’s
behalf and will reimburse such Investor, and each such officer, director or member and each such controlling person for any legal
or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability
or action; provided, however, that the Company will not be liable in any such case if and to the extent that any
such loss, claim, damage or liability arises solely out of or is based solely upon an untrue statement or alleged untrue statement
or omission or alleged omission so made in conformity with information furnished by such Investor or any such controlling person
in writing specifically for use in such Registration Statement or Prospectus. In connection with an underwritten offering, the
Company will indemnify the underwriters selected by VB Funding, their respective officers and directors and each person who controls
(within the meaning of the 1933 Act) such underwriters at least to the same extent as provided above with respect to the indemnification
of the holders of Registrable Securities.

 

(b)          Indemnification
by the Investors. Each Investor agrees, severally but not jointly, to indemnify and hold harmless, to the fullest extent permitted
by law, the Company, its directors, officers, employees, stockholders and each person who controls the Company (within the meaning
of the 1933 Act) against any losses, claims, damages, liabilities and expense (including reasonable attorney fees) resulting from
any untrue statement of a material fact or any omission of a material fact required to be stated in the Registration Statement
or Prospectus or preliminary Prospectus or amendment or supplement thereto or necessary to make the statements therein not misleading,
to the extent, but only to the extent that such untrue statement or omission is contained in any information furnished in writing
by such Investor to the Company specifically for inclusion in such Registration Statement or Prospectus or amendment or supplement
thereto. In no event shall the liability of an Investor be greater in amount than the dollar amount of the proceeds (net of all
expense paid by such Investor in connection with any claim relating to this Section 6 and the amount of any damages such Investor
has otherwise been required to pay by reason of such untrue statement or omission) received by such Investor upon the sale of the
Registrable Securities included in the Registration Statement giving rise to such indemnification obligation.

 

    	 	9	 

     

    

 

(c)          Conduct
of Indemnification Proceedings. Any person entitled to indemnification hereunder shall (i) give prompt notice to the indemnifying
party of any claim with respect to which it seeks indemnification and (ii) permit such indemnifying party to assume the defense
of such claim with counsel reasonably satisfactory to the indemnified party; provided that any person entitled to indemnification
hereunder shall have the right to employ separate counsel and to participate in the defense of such claim, but the fees and expenses
of such counsel shall be at the expense of such person unless (a) the indemnifying party has agreed to pay such fees or expenses,
(b) the indemnifying party shall have failed to assume the defense of such claim and employ counsel reasonably satisfactory to
such person, or (c) in the reasonable judgment of any such person, based upon written advice of its counsel, a conflict of interest
exists between such person and the indemnifying party with respect to such claims (in which case, if the person notifies the indemnifying
party in writing that such person elects to employ separate counsel at the expense of the indemnifying party, the indemnifying
party shall not have the right to assume the defense of such claim on behalf of such person); and provided, further,
that the failure of any indemnified party to give notice as provided herein shall not relieve the indemnifying party of its obligations
hereunder, except to the extent that such failure to give notice shall materially adversely affect the indemnifying party in the
defense of any such claim or litigation. It is understood that the indemnifying party shall not, in connection with any proceeding
in the same jurisdiction, be liable for fees or expenses of more than one separate firm of attorneys at any time for all such indemnified
parties. No indemnifying party will, except with the consent of the indemnified party, consent to entry of any judgment or enter
into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified
party of a release from all liability in respect of such claim or litigation.

 

(d)          Contribution.
If for any reason the indemnification provided for in the preceding paragraphs 6(a) and 6(b) is unavailable to an indemnified party
or insufficient to hold it harmless, other than as expressly specified therein, then the indemnifying party shall contribute to
the amount paid or payable by the indemnified party as a result of such loss, claim, damage or liability in such proportion as
is appropriate to reflect the relative fault of the indemnified party and the indemnifying party, as well as any other relevant
equitable considerations. No person guilty of fraudulent misrepresentation within the meaning of Section 11(f) of the 1933 Act
shall be entitled to contribution from any person not guilty of such fraudulent misrepresentation. In no event shall the contribution
obligation of a holder of Registrable Securities be greater in amount than the dollar amount of the proceeds (net of all expenses
paid by such holder in connection with any claim relating to this Section 6 and the amount of any damages such holder has otherwise
been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission) received by it upon
the sale of the Registrable Securities giving rise to such contribution obligation.

 

7.           Miscellaneous.

 

(a)          Amendments
and Waivers. This Agreement may be amended only by a writing signed by the Company and VB Funding. The Company may take any
action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company shall have obtained
the written consent to such amendment, action or omission to act, of VB Funding, in its sole discretion.

 

(b)          Notices.
All notices and other communications provided for or permitted hereunder shall be made as set forth in Section 4.11 of the Credit
Agreement.

 

    	 	10	 

     

    

 

(c)          Assignments
and Transfers by Investors. The provisions of this Agreement shall be binding upon and inure to the benefit of the Investors
and their respective successors and assigns. An Investor may transfer or assign, in whole or from time to time in part, to one
or more persons its rights hereunder in connection with the transfer of Registrable Securities by such Investor to such person,
provided that such Investor complies with all laws applicable thereto and provides written notice of assignment to the Company
promptly after such assignment is effected.

 

(d)          Assignments
and Transfers by the Company. This Agreement may not be assigned by the Company (whether by operation of law or otherwise)
without the prior written consent of VB Funding, in its sole discretion; provided, however, that in the event that the Company
is a party to a merger, consolidation, share exchange or similar business combination transaction in which the Common Stock is
converted into the equity securities of another Person, from and after the effective time of such transaction, such Person shall,
by virtue of such transaction, be deemed to have assumed the obligations of the Company hereunder, the term “Company”
shall be deemed to refer to such Person and the term “Registrable Securities” shall be deemed to include the securities
received or to be received by the Investors in connection with such transaction (as though the Note and the Warrants had been converted
into shares of Common Stock immediately prior to such transaction) unless such securities are otherwise freely tradable by the
Investors after giving effect to such transaction.

 

(e)          Benefits
of the Agreement. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective
permitted successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any
party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities
under or by reason of this Agreement, except as expressly provided in this Agreement.

 

(f)           No
Inconsistent Agreements. The Company will not on or after the date hereof enter into any agreement with respect to its securities
which is inconsistent with the rights granted to the holders of Registrable Securities in this Agreement or otherwise conflicts
with the provisions hereof. The rights granted to holders of Registrable Securities hereunder do not in any way conflict with any
other agreement to which the Company is a party.

 

(g)          Remedies.
All remedies under this Agreement, or by law or otherwise afforded to any party hereto, shall be cumulative and not alternative.
Any person having rights under any provision of this Agreement will be entitled to enforce such rights specifically to recover
damages caused by reason of any breach of any provision of this Agreement and to exercise all other rights granted by law. The
parties hereto agree and acknowledge that money damages may not be an adequate remedy for any breach of the provisions of this
Agreement and that any party may in its sole discretion apply to any court of law or equity of competent jurisdiction (without
posting any bond or other security) for specific performance and for other injunctive relief in order to enforce or prevent violation
of the provisions of this Agreement.

 

(h)          Delays
or Omissions. No failure to exercise or delay in the exercise of any right, power or remedy accruing to a holder on any breach
or default of the Company under this Agreement shall impair any such right, power or remedy nor shall it be construed to be a waiver
of any such breach.

 

    	 	11	 

     

    

 

(i)           Counterparts;
Faxes. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument. This Agreement may also be executed via facsimile, which shall be deemed
an original.

 

(j)           Titles
and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement.

 

(k)          Severability.
Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective
to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof but shall be interpreted
as if it were written so as to be enforceable to the maximum extent permitted by applicable law, and any such prohibition or unenforceability
in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. To the extent permitted
by applicable law, the parties hereby waive any provision of law which renders any provisions hereof prohibited or unenforceable
in any respect.

 

(l)           Further
Assurances. The parties shall execute and deliver all such further instruments and documents and take all such other actions
as may reasonably be required to carry out the transactions contemplated hereby and to evidence the fulfillment of the agreements
herein contained.

 

(m)         Entire
Agreement. This Agreement is intended by the parties as a final expression of their agreement and intended to be a complete
and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein.
This Agreement supersedes all prior agreements and understandings between the parties with respect to such subject matter.

 

(n)          Governing
Law; Consent to Jurisdiction; Waiver of Jury Trial. This Agreement shall be governed by, and construed in accordance with,
the internal laws of the State of New York without regard to the choice of law principles thereof. Each of the parties hereto irrevocably
submits to the exclusive jurisdiction of the courts of the State of New York located in New York County and the United States District
Court for the Southern District of New York for the purpose of any suit, action, proceeding or judgment relating to or arising
out of this Agreement and the transactions contemplated hereby. Service of process in connection with any such suit, action or
proceeding may be served on each party hereto anywhere in the world by the same methods as are specified for the giving of notices
under this Agreement. Each of the parties hereto irrevocably consents to the jurisdiction of any such court in any such suit, action
or proceeding and to the laying of venue in such court. Each party hereto irrevocably waives any objection to the laying of venue
of any such suit, action or proceeding brought in such courts and irrevocably waives any claim that any such suit, action or proceeding
brought in any such court has been brought in an inconvenient forum.  EACH OF THE PARTIES HERETO WAIVES ANY RIGHT TO REQUEST
A TRIAL BY JURY IN ANY LITIGATION WITH RESPECT TO THIS AGREEMENT AND REPRESENTS THAT COUNSEL HAS BEEN CONSULTED SPECIFICALLY AS
TO THIS WAIVER.

 

(Remainder of page intentionally left blank.
Signature page to follow.)

 

    	 	12	 

     

    

 

IN WITNESS WHEREOF, the parties
have executed this Agreement or caused their duly authorized officers to execute this Agreement as of the date first above written.

 

	 	Company:
	 	 
	 	GRANDPARENTS.COM, INC.
	 	 	 
	 	By:	/s/ Steve Leber
	 	 	Name: Steve Leber
	 	 	Title: Chairman & CEO
	 	 	 
	 	VB Funding:
	 	 
	 	VB FUNDING, LLC
	 	 	 
	 	By:	/s/ Vincent J. Dowling, Jr.
	 	 	Name: Vincent J. Dowling, Jr.
	 	 	Title: Managing Member

 

[Signature Page to Amended and Restated Registration
Rights Agreement]

 

    	 	 

     

    

 

Exhibit A

 

Plan of Distribution

 

The selling stockholders,
as used herein includes donees, pledgees, transferees or other successors-in-interest selling shares of common stock or interests
in shares of common stock received after the date of this prospectus from a selling stockholder as a gift, pledge, partnership
distribution or other transfer, may, from time to time, sell, transfer or otherwise dispose of any or all of their shares of common
stock or interests in shares of common stock on any stock exchange, market or trading facility on which the shares are traded or
in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices
related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices.

 

The selling stockholders
may use any one or more of the following methods when disposing of shares or interests therein:

 

- ordinary brokerage transactions
and transactions in which the broker-dealer solicits purchasers;

 

- block trades in which
the broker-dealer will attempt to sell the shares as agent, but may position and resell a portion of the block as principal to
facilitate the transaction;

 

- purchases by a broker-dealer
as principal and resale by the broker-dealer for its account;

 

- an exchange distribution
in accordance with the rules of the applicable exchange;

 

- privately negotiated
transactions;

 

- short sales effected
after the date the registration statement of which this Prospectus is a part is declared effective by the SEC;

 

- through the writing or
settlement of options or other hedging transactions, whether through an options exchange or otherwise;

 

- broker-dealers may agree
with the selling stockholders to sell a specified number of such shares at a stipulated price per share;

 

- a combination of any
such methods of sale; and

 

- any other method permitted
by applicable law.

 

    	 	A-1	 

     

    

 

The selling stockholders
may, from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by them and, if
they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of
common stock, from time to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or other
applicable provision of the Securities Act amending the list of selling stockholders to include the pledgee, transferee or other
successors in interest as selling stockholders under this prospectus. The selling stockholders also may transfer the shares of
common stock in other circumstances, in which case the transferees, pledgees or other successors in interest will be the selling
beneficial owners for purposes of this prospectus.

 

In connection with the
sale of our common stock or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions
they assume. The selling stockholders may also sell shares of our common stock short and deliver these securities to close out
their short positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling
stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation
of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares
offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus
(as supplemented or amended to reflect such transaction).

 

The aggregate proceeds
to the selling stockholders from the sale of the common stock offered by them will be the purchase price of the common stock less
discounts or commissions, if any. Each of the selling stockholders reserves the right to accept and, together with their agents
from time to time, to reject, in whole or in part, any proposed purchase of common stock to be made directly or through agents.
We will not receive any of the proceeds from this offering. Upon any exercise of the warrants by payment of cash, however, we will
receive the exercise price of the warrants.

 

The selling stockholders
also may resell all or a portion of the shares in open market transactions in reliance upon Rule 144 under the Securities Act of
1933, provided that they meet the criteria and conform to the requirements of that rule.

 

The selling stockholders
and any underwriters, broker-dealers or agents that participate in the sale of the common stock or interests therein may be “underwriters”
within the meaning of Section 2(a)(11) of the Securities Act. Any discounts, commissions, concessions or profit they earn on any
resale of the shares may be underwriting discounts and commissions under the Securities Act. Selling stockholders who are “underwriters”
within the meaning of Section 2(a)(11) of the Securities Act will be subject to the prospectus delivery requirements of the Securities
Act.

 

To the extent required,
the shares of our common stock to be sold, the names of the selling stockholders, the respective purchase prices and public offering
prices, the names of any agents, dealer or underwriter, any applicable commissions or discounts with respect to a particular offer
will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement
that includes this prospectus.

 

    	 	2	 

     

    

 

In order to comply with
the securities laws of some states, if applicable, the common stock may be sold in these jurisdictions only through registered
or licensed brokers or dealers. In addition, in some states the common stock may not be sold unless it has been registered or qualified
for sale or an exemption from registration or qualification requirements is available and is complied with.

 

We have advised the selling
stockholders that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of shares in the market
and to the activities of the selling stockholders and their affiliates. In addition, to the extent applicable we will make copies
of this prospectus (as it may be supplemented or amended from time to time) available to the selling stockholders for the purpose
of satisfying the prospectus delivery requirements of the Securities Act. The selling stockholders may indemnify any broker-dealer
that participates in transactions involving the sale of the shares against certain liabilities, including liabilities arising under
the Securities Act.

 

We have agreed to indemnify
the selling stockholders against liabilities, including liabilities under the Securities Act and state securities laws, relating
to the registration of the shares offered by this prospectus.

 

We have agreed with the
selling stockholders to keep the registration statement of which this prospectus constitutes a part effective until the earlier
of (1) such time as all of the shares covered by this prospectus have been disposed of pursuant to and in accordance with the registration
statement or (2) the date on which all of the shares may be sold without restriction pursuant to Rule 144 of the Securities Act.

 

    	 	3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}]]